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Thesis Abstract  
 
Our central nervous system employs strict regulation of the trace element copper, and dysregulation 
is implicated in the neuropathology of many neurodegenerative and neurocognitive diseases. Recent 
interest into the contribution of copper dysregulation to neurological disease has exposed our 
limited understanding of neuronal copper homeostasis. For instance, known uptake mechanisms do 
not completely account for cellular copper concentrations, suggesting alternate mechanisms remain 
to be found. Past work has established that some neuropeptides can bind copper, with the 
tachykinin neuropeptide, Neurokinin B (NKB), able to form an unusual complex with copper. Other 
recent approaches focusing on NKB and its corresponding receptor NK3R, identified the 
endogenous ligand-induced translocation of NK3R to the nucleus. Further, the newly identified 
copper-NKB complex has been shown to not inhibit receptor uptake, however intracellular 
localisation and interactions are unknown. To identify copper-NKB complex induced changes 
intracellularly, we used Confocal microscopy, Spectral phasor analysis, and Inductively Coupled 
Plasma-Mass Spectrometry to determine receptor localisation and copper concentrations in human 
astrocyte cell line. Our results indicate that receptor–mediated endocytosis (RME), particularly of 
the [Cu(NKB)2]/NK3R complex contributes to cellular copper levels. Additionally, nuclear 
trafficking of the receptor and nuclear copper concentrations increase when exposed to the 
[Cu(NKB)2] complex. Furthermore, results illustrate that this process may be clathrin-mediated, but 
in the absence of clathrin, can utilise a clathrin-independent pathway. This is indicative of a novel 
CNS-specific copper trafficking pathway, due to the CNS-specific expression of NKB. This study 
establishes a foundation for future neurobiological research into the underlying role RME plays in 
copper regulation within the CNS. 
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Chapter One: Introduction 
 
Metal Metabolism  
1.1.1 Overview 
The existence of life is reliant upon metal ions. From our inorganic origins in the primordial soup 
approximately 3.5 billion years ago, to driving metabolism via metal-enriched enzymes, our 
comprehension of metal metabolism is imperative to understanding the ontology of bioinorganic 
chemistry with respect to human function and disease.1,2 Trace amounts of inorganic metals are 
necessary for normal physiological function. Biologically significant trace elements include copper, 
zinc, iron, iodine, manganese, cobalt, selenium and molybdenum.1 The transitional ionic 
coordination properties of metals play a crucial role in the formation of both catalytic and structural 
functions within many proteins.3 Metalloproteins are proteins that contain metal binding sites, and 
are thought to make up approximately half of all proteins within the human body.3,4 The binding 
and release of a metal serves as a regulatory mechanism, inactivating or catalysing the protein into 
action. Other proteins rely on the reduction / oxidation properties of a metal to carry out its task and 
must structurally contain a metal at all times in its core active site in order to remain functional.5  
The uptake, transport and release of these trace elements via numerous other proteins and pathways 
permits many essential intracellular functions. However, some more redox active free metals within 
cells are known to cause oxidative stress that leads to apoptosis. In order to overcome this, cells 
implement a strict, complex system of regulation, allowing metals such as copper, to serve their 
purpose without detriment to the cell.  
1.1.2 The Central Nervous System and metal metabolism 
The brain comprises of many different cells with distinct functions that collectively form the central 
nervous system (CNS). Cells are taxonomically divided between excitory and non-excitory, 
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expressly neurons and glial cells6, with further division of the latter to oligodendrocytes, astrocytes, 
ependymal cells and microglia. Within astrocytes, there are functionally diverse subpopulations that 
manifest varying region-specific activity. These activities range from synaptogenesis, neuropeptide 
secretion, regulating haemodynamic responses, to regulation of metabolites.7 The diversity of 
astrocytic progenitor origin, morphology and location further diverges them taxonomically into 
bergmann glia, smooth protoplasmic, velate astrocytes, and fibrous astrocytes. Thus, astrocytes are 
comprised of a highly diverse populace within the CNS.8 
Astrocytes are unique in their star-like composition, conveniently located in critical positions in the 
CNS that allow dynamic responses to their environment.6 Geospatially, astrocytes project numerous 
processes with minimal overlap, forming an organised structural area, with some astrocytes 
(protoplasmic) concentrated around neuronal synapses both pre and post synaptically.6 These 
processes express a wide variety of ion channels and receptors that are crucial to normal brain 
function, allowing interaction with the synapse and surrounding blood vessels via the end feet of 
these processes.6,7 Astrocytes actively function as metal depositories and regulators for the 
distribution of essential metals to other neurons and glial cells.9 Astrocytes are key regulators of 
metabolites entering, circulating, and exiting the CNS. The cells are uniquely located in the brain 
where they form a complex of functional networks that ultimately links neurons to brain capillaries. 
By connecting blood vessels to neurons (and synapses), astrocytes can dynamically respond to 
neuronal metabolic needs, regulate transmission and therefore act as a gatekeeper, regulating 
incoming metals and directing them where required.6  
Astrocytes are unique as they possess key machinery to allow greater storage of metals.10 
Metallothioneins are crucial components in metal deposition that are found in significant 
concentrations in the cytoplasm of astrocytes.10,11,12 They are proteins that have a cysteine-rich 
composition which promotes a high affinity for divalent metal ions and allows them to chelate and 
temporarily store unbound metals.  Glutathione is a glycine–cysteine–-glutamate tripeptide mainly 
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expressed in astrocytes that is primarily involved in maintaining the redox balance in the 
cytosol.10,13 However, reduced glutathione also plays a role in the regulation of copper within 
astrocytes and it is thought that a cytosolic labile copper pool includes copper-glutathione 
complexes. Changes to the glutathione concentration can result in free copper, allowing copper to 
bind to any cysteine thiols found on many essential enzymes which can inactivate the protein.13 
When in the presence of oxygen, oxidation of a newly formed metal-thiolate bond results in 
cysteine cross linkage and the formation of a disulphide bond. However, specifically for some 
metals such as copper, the co-ordination properties of the metal result in a strong copper-thiolate 
bond, meaning that the for enzymes, inactivation can be irreversible.13  
Astrocytes are interesting because of their intracellular localisation of many integral metal-
dependent enzymes required for proper brain function. These include glutamine synthetase,14 Cu, 
Zn-superoxide dismutase,15 and copper transporters ATP7A (Cu–ATPase).17 Astrocyte-specific 
compartmentalisation of metals play an integral part in metal regulation within the CNS, and 
utilisation of all the above machinery is essential in maintaining both astrocytic and neuronal metal 
homeostasis. Effective storage of metals within astrocytes is imperative to many essential processes 
that require metals for their function. Metals such as iron and copper, are required for the synthesis 
and degradation of many monoamine neurotransmitters, including Dopamine and Serotonin.18,19,20 
Furthermore, many degradation pathways require transition metals and ascorbic acid, which 
operates as a co-factor in the reduction of metals.18  
In addition to the key regulatory role astrocytes play in the CNS, the brain is also made up of a 
complex circuitry network, consisting of billions of neurons, coupling via trillions of synaptic 
connections.21 Taxonomically, neurons are diverse in their molecular, morphological, connectional 
and functional properties.22 A fundamental element to neuronal communication is the synapse, 
where the physical meeting point of two neurons structurally allows the arrival of an electrical 
action potential to transmit a signal to the next neuron via the release of neurotransmitters. This 
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release of neurotransmitters chemically interacts with corresponding receptors on the post-synaptic 
cell, triggering various intracellular signalling cascades to trigger a response.21 Synaptic 
transmission is the decisive process undertaken in the brain that governs neural circuitry and indeed 
the operational governance of the CNS.  
Recent evidence provides compelling insight into how metals play an influential role in neuronal 
processes. At the site of synaptic transmission, the synaptic cleft, it is well established that upon 
depolarization, free copper is released from synaptic vesicles into the cleft.23,24 Copper is known to 
facilitate modulation of neurotransmitter interactions with receptors at synapses, trigger synaptic 
vesicular trafficking, regulate protein interactions in secretory vesicle pathways, and trigger 
protection mechanisms within neural cells, to counter excitotoxicity.23,25,26,27 In addition, copper is 
known to also influence neurotransmitter formation and release, modulation of synaptic activity and 
plasticity.27 In the case of Norepinephrine formation, copper dependent dopamine-β-hydroxylase 
catalyses the formation of dopamine from ascorbate, with further hydroxylation to form 
norepinephrine from dopamine.20 The copper chelating compound Neocuproine has been shown to 
modulate the expression of dynamin and synapsin in hippocampal neurons, reducing presynaptic 
Ca2+ influx and dampening synaptic activity.27 This model illustrates a model of possible copper 
dependent modulation of synaptic activity, with the study hypothesizing that dynamin and synapsin 
may be a possible drug target for neuronal hyper-excitability such as that seen in epilepsy. 
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Figure 1- Copper-mediated interactions at the synapse. Copper interacts with many 
constituents in the synapse, with up to 250M of copper released into the synaptic cleft from 
synaptosomes upon depolarisation.23 Copper in the synapse is thought to be released in the 
oxidised state (Cu2+) with the binding of Cu2+ to many post synaptic cell surface 
neurotransmitter receptors.24 Cu2+ blocks NMDA receptor activity by binding non-competitively 
to the receptor, acting as an antagonist, inhibiting the excitory effect (Ca2+ influx) mediated by 
glutamate. Cu2+ binds to APP, triggering its formation as a dimer. Cu2+ is reduced by ascorbate-
mediated reductases and enters the cell via CTR1, with Atox1 transferring Cu1+ to ATP7A, which 
resides at the Trans-Golgi Network (TGN). It then translocates, trafficking copper either back to 
the surface or to other cytosolic destinations.  Copper-mediated AMPAR inhibition is thought to 
occur due to Cu2+ catalysing cysteine oxidation in the receptor. In situations where there is long 
term potentiation, copper’s effect on the receptors is reversed, causing an excitory response, 
encouraging receptor clustering.24   
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In the case of copper following extracellular uptake via a plasma membrane associated copper 
transporter such as Ctr1, to reduce the risk of toxicity of accumulation within the cytoplasm, the 
human copper chaperone Atox1 transports copper to either ATP7a or ATP7b for uptake into the 
trans-Golgi network.28 Once in the Golgi apparatus, as part of post translational modification of 
proteins, Cu is then incorporated into copper-dependent enzymes.  
Following post translational modification of metal-carrying proteins, Heat shock protein 70 (Hsp70) 
can bind to these proteins to aid in their safe passage. Hsp70 is an additional element in the 
transportation of proteins, specifically for metalloproteins within cells. It aids in the transmembrane 
transport of proteins exposed to metals such as copper and iron by binding to a protein’s 
hydrophobic residues caused by oxidative stress.29 This in turn stabilises partially denatured 
proteins that may be in a partially folded state and prevents protein aggregation.29 Additionally, 
Hsp70 can also be phosphorylated,30 regulating its interactions with Protein Kinase C and any 
resulting calcium flux. 
Other chaperones can traffic copper to specific cuproproteins, for instance, the antioxidant protein 
superoxide dismutase (SOD) requires copper delivered by CCS, the Copper Chaperone for SOD.31 
The facilitated uptake of copper via plasma membrane proteins Ctr1 and Divalent Metal 
Transporter 1 (DMT1) is well documented, yet undescribed alternate uptake mechanisms exist and 
remain unidentified.31 In one study, where Ctr1 was knocked out in mouse embryonic cells, there 
was still up to 30% of copper uptake occurring,31 substantiating the idea of alternate uptake 
mechanisms. An isoform of Ctr1, Ctr2, has been proposed to play a role in copper uptake, however 
when overexpressed, it did not increase cellular copper concentrations, leaving the possibility of 
unknown mechanisms open.32 
1.1.3 Intracellular metal metabolism 
Although the mechanisms involved in cellular trafficking of metals are reasonably well understood, 
the transportation of metals to the intracellular compartments like the nucleus is an underexplored 
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area of metal homeostasis. This is in contrast to the known functional properties for some metals in 
the nucleus, such as the role of zinc as a structural cofactor in zinc-finger transcription factors. 
Entry into the nucleus is highly regulated and metals are likely to require a protein partner for 
access. To this end, the protein transporting the metal will need to contain a nuclear localisation 
sequence (NLS). The NLS is a specified sequence of amino acids that tag a protein for passage to 
the nucleus. Proteins containing two clusters of basic amino acids separated by a short acidic amino 
acid spacer sequence within their NLS are classed as bipartite (KRXXXXXXXKKK, where bold 
denotes the NLS and the X denotes the spacer sequence), and those with an uninterrupted sequence 
termed monopartite (KKKRK). This difference in basic and acidic amino acid sequence structure is 
thought to lead to differences in nuclear localization efficiencies, with monopartite sequences 
having a greater efficiency than their bipartite counterparts.33  
The initiation of nuclear localisation begins with the binding of the NLS to an importin subunit. 
Nuclear localisation is known to be undertaken either via a direct route, binding to importin β, or 
via an indirect method by binding to importin α.34 Acting as an adapter protein, importin α has 
direct contact with the NLS of a to be imported protein, which then binds to importin β to form the 
heterodimeric importin complex, enabling the actual trafficking to the nuclear pore complex.34 
Once inside the nucleus, both importins will disassociate from the NLS site of the protein when it 
encounters RanGTP.34  
Another key element for nuclear translocation is the formation of the Nuclear Pore Complex itself 
prior to interacting with importins. The NPC forms when the inner and outer nuclear membrane 
fuse together, allowing channels to form across the nuclear envelope. These channels allow 
selective transport between the nucleus and the cytoplasm. Architecturally, NPCs are a culmination 
of multiple and different highly conserved nucleoporins coming together, up to a thousand 
nucleoporins with a combined molecular mass of approximately 120 millidaltons (MDa) in humans 
and an approximate diameter of 20-50 nm.35,36 The NPC displays an octagonal rotational symmetry, 
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consisting of many distinct substructures, with the cytoplasmic face inherently containing 
disordered domains that are highly adaptable.36 This permits the entry of many different structures 
into the NPC, including proteins, RNA, and metal ions.   
Once inside the nucleus, a translocated metalloprotein may be compartmentalised into nuclear sub-
organelles.37 Within the nucleus, many domains exist, such as; chromosomes, nucleoli, cajal bodies, 
and speckles, each with their own particular functions. Nucleoli are well regarded as sites for 
ribosomal RNA transcription, modification and pre-assembly, editing of mRNA, and the assembly 
of ribonucleoproteins.37 Cajal Bodies are concentrated with factors implicated to control nuclear 
RNA biogenesis, histones, snRNA genes, and interestingly, Survival of Motor Neurons (SMN) 
protein, that when dysregulated, results in spinal muscular atrophy.37 Speckles, influenced by 
mRNA transcription and protein phosphorylation, is the primary site for the production of splicing 
related proteins.37   
Many metals including copper, are known to interact with components of some of these domains, 
eliciting numerous responses and serving many regulatory functions. Cu2+ induces H4 histone 
hypo-acetylation through a direct mode of inhibition upon the histone acetyltransferase (HAT) 
protein.38 This is attributed to the binding of copper to cysteine or histidine residues within critical 
areas of the protein. This affects gene silencing, which is regulated by the histone acetylation status. 
Copper is known to induce activation of transcription factors (nuclear factor kappa B and metal 
transcription factor 1) and bind directly to DNA to induce chromatin remodelling.39,40 However in 
contrast, it has also been reported that when Cu2+ is delivered to a cell in a complex with peptides 
via endocytosis, NFκB activation is inhibited by the complex.41 However, in that study, it was not 
determined if the Cu2+-peptide complex was present in the nucleus or only the cytosol. Although 
the presence of copper in the nucleus is well-established, only some of the functional roles within 
the nucleus are known.  
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Diseases and Disorders of the CNS 
1.2.1 Copper-Induced disease 
Metals play a fundamental role in cellular homeostatic functioning, and as such, when dysregulation 
occurs, forms part of the aetiology of many detrimental diseases. Many neurodegenerative disorders 
such as, Alzheimer’s disease (AD), Parkinson’s disease (PD) and Amyotrophic lateral sclerosis 
(ALS), commonly feature disruptions in copper metabolism.42,43  
Characteristically, AD is described as the excessive aggregation of amyloid-beta (Aβ), forming 
deposits known as plaques within the brain, compounded by excessive tau phosphorylation induced 
neurofibrillary tangles.44 These areas of plaque and tangle formation attract reactive astrocytes and 
activated microglia in an attempt by the CNS to intervene via an immunological response. This 
response results in associated neuro-inflammation, however, plaque formation concludes with the 
destruction of neurons and astrogliosis, inflicting many debilitating symptoms upon the sufferer 
until their eventual death. Reactive astrocytic gliosis causes a fundamental shift in the CNS, with 
molecular changes in the way astrocytes regulate metabolites, and dysfunction compromising 
localised and broader network level neuronal communication.44  
Reactive gliosis causes an elemental breakdown in copper-mediated neurotransmitter and calcium 
signalling, recycling, and potassium buffering.44 In the case for Alzheimer’s Disease, reactive 
gliosis occurs at the site of plaque aggregation. Astrocytes internalise significant volumes of β-
amyloid in an attempt to minimise the destructive aggregation. This results in glutathione depletion, 
subsequent free copper-induced oxidative stress, exerting oscillating Ca2+ waves, inducing 
excitotoxicity upon nearby neurons, culminating in surrounding neuronal death.45 The mechanism 
by which astrocyte-derived oscillating Ca2+ waves trigger neuronal excitotoxicity, is via normal 
functional Ca2+ induced exocytosis of glutathione (GSH), known to modulate synaptic transmission 
via the promotion of neuronal excitability and neuronal synchrony.46 Furthermore, activated 
astrocytes release a significant array of neurotrophic factors, cytokines, chemokines, and reactive 
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oxygen species into the surrounding environment, mediating a neuroinflammatory response.45 This 
depletion in GSH is particularly important when discussing oxidative stress. GSH is necessary for 
the binding of free-copper, forming a complex once Cu+ is transported into the cell via the Ctr1-
mediated pathway. Once bound, the transfer of copper to a metallothionein for long term storage 
ensures minimal free copper intracellularly and mitigates the risk of free copper disrupting normal 
cellular functions.47  
It is well-established that for AD, copper binds to amyloid precursor protein (APP), promoting its 
dimerisation and thus permitting greater amyloid β (Aβ) production.48 Also, it is known that Aβ has 
a high affinity specifically for Cu2+ ions.49 These Aβ -copper complexes catalyse oxidative stress in 
the CNS, with the Cu2+-bound Aβ peptide able to degrade hydrogen peroxide to carbonyls and 
hydroxyls.50 Reactive oxygen species can cause conformational changes in proteins, DNA damage, 
and lipid peroxidation and thus reducing cell viability.51 Copper is thought to  interrupt the 
progression of Aβ fibrillogenesis and instead promote the formation of amorphously arranged A 
This occurs via the binding of Cu2+ions to the available copper binding sites within Aβ.52  Further, 
the composition of excessive Aβ plaque aggregation contains significantly high copper 
concentrations (up to 400 µM).53 However, there are many aspects of cellular copper regulation that 
is still very unclear. As a result, whether excessive copper accumulation is symptomatic or 
causative of the pathogenesis of Alzheimer’s disease is highly debatable and yet to be conclusively 
elucidated.  
1.2.2 Cognition loss and its relationship with copper 
Recently, attempts to improve our understanding of the neurobiological basis of many mental 
illnesses, and better definition of mental disturbances associated with neurodegenerative diseases, 
has resulted in the novel taxonomical category of neurocognitive disorders. This classification of 
many neurological illnesses into this category has unveiled an unexpected commonality, that is, 
dysregulation of copper metabolism is significantly present in many of these illnesses. The link 
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between copper metabolism and cognition is an exciting development, and efforts to improve our 
knowledge of copper metabolism biologically, serves to diversify possibilities for treatment.   
Presently, any symptoms of cognition loss in neurological disease is defined by the fifth edition of 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).56 The DSM-5 describes 
aetiologically, cognitive syndromes and their subtypes to provide a universal language for both 
clinicians and researchers to use when describing cognition loss (Table 1).56 Cognition loss in 
neurodegenerative and neurological disease is differentiated from neurodevelopmental disorders, 
due to the lack of neurobiological abnormalities during development in the former.  
Table 1- Cognitive function comprises of six key domains. Note: Information and classification 
from the American Psychiatric Association. Diagnostic and statistical manual of mental 
disorders (DSM-5®). American Psychiatric Pub; 2013 May 22. Table adapted from PS Sachdev 
et al.56 
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Biologically, cognition loss has been associated with many changes that occur as part of many 
neuropathies. The hippocampus is synonymous with normal cognitive functions, responsible for 
memory, spatial perception, and the attention / inhibition response. In one study, post-mortem tissue 
from AD associated mild cognitive decline sufferers, revealed a significant reduction in 
hippocampal synapses early in disease progression compared to those with normal cognition.57 This 
parallels may other experimental observations, associating hippocampal synaptic loss with 
cognition loss. Furthermore, it is in agreement with a study that concluded for AD, lower neuronal 
counts and volumes of neurofibrillary tangles, not Aβ density correlated with disease associated-
cognition loss.58 Previously, cognition loss has been attributed to the copper-induced generation of 
reactive oxygen species that results ultimately in neuronal death.59 This copper-induced oxidative 
stress has been shown to decimate nigrostriatal dopaminergic neurons and paraventricular nuclei 
within the hypothalamus, areas implicated in many neurodegenerative diseases.60,61  
Recently, a post-mortem study on schizophrenic patients identified abnormalities in the copper 
transporters ATP7a and CTR1 locally in cells of the Substantia Nigra, the same locality implicated 
for cognition loss in Alzheimer’s disease.62 It has been long suspected that copper dysregulation 
may play an integral part in perpetuating dysregulation of the dopaminergic system. Interacting 
with dopaminergic regulation, excess copper is known to shunt tyrosine away from L-3,4-
dihydroxyphenylalanine (DOPA) production via the copper-dependent enzyme tyrosinase, 
inhibition of  the DOPA-decarboxylase step in dopamine production, excess binding of copper to 
the copper-dependent enzyme dopamine beta-hydroxylase, catalysing the breakdown of dopamine 
into norepinephrine, and excess monoamine oxidase (MAO) induced dopamine degradation.63 This 
theory of involvement developed from many past studies identifying elevated copper and 
Ceruloplasmin (a copper binding protein) levels within the sera of Schizophrenic patients.64,65   
Alterations in the expression of key copper transport proteins, ATP7a and ATP7b which disrupts 
cellular copper translocation and accumulation, features in Menkes and Wilsons disease.66 In these 
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diseases, dysregulation of copper levels may result in significant psychiatric, cognitive and 
neurological disturbances.67  It has also been established that, so great can the symptoms be of 
cognitive and psychiatric disturbance, that many cases of Wilsons disease sufferers misdiagnosed as 
schizophrenia exist.68  Interestingly in Menkes Disease, administration of a copper-histidine 
complex results in effective brain uptake of copper, normalization of copper, ceruloplasmin, 
dopamine, and norepinephrine levels within patient sera, and relief of disease-induced neurological 
deficits.69 Furthermore, it was speculated that in order to overcome connective tissue symptoms, 
subcutaneous injections of both Cu+ and Cu2+ complexes were required.70 This illuminates an 
intriguing aspect, that intracellular differences in  Cu+ and Cu2+ metabolism plays distinct roles in 
metal-induced disease, and that dysregulation of Cu+ homeostasis specifically may be implicated in 
cognitive and psychiatric dysfunction. However, deficient exploration of cellular copper 
subpopulations and interactions of copper binding complexes represent a significant void in our 
understanding.   
1.2.3 Neuropeptides and copper  
Together, both cuprous and cupric ions play important roles in numerous chemical and biochemical 
processes.71 As such, understanding the interactions between copper and various peptides is integral 
to appreciating copper’s intricate contribution to disease.  
The formation of copper-binding complexes is usually interceded by the presence of an amino acid 
with suitable binding properties, particularly Cys, and His residues. Many cuproproteins are rich in 
nucleophilic cysteine-derived thiol groups, available for deprotonation and binding directly to 
copper.72 For histidine, binding may occur via the imidazole nitrogen and/or the amide nitrogen.73 
In fact, many neuropeptides are known to bind copper via their His residues, including PrP, NKB, 
and β-amyloid.74,75,76 Coincidently, all three of these peptides coordinate with Cu2+ ions, with two 
of these peptides containing an ATCUN (amino terminal copper and nickel) binding motif (Fig. 2). 
In peptides that contain an ATCUN binding site, the histidine residue is found at position 3, 
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allowing specific high affinity binding to and release of metals.77 Previously, utilization of ATCUN 
binding motifs within synthetic peptides capable of binding copper, have shown that the ATCUN 
sequence is a high affinity Cu2+ binding site(log Ka∼11), resulting in greater bioavailability of 
copper for cellular uptake.78 This illustrates the idea that peptides can facilitate greater copper 
uptake via the incorporation of an ATCUN motif.  
 
Tachykinins are a sub-class of neuropeptides, responsible physiologically for inducing neuronal 
excitation via their signalling, evoking behavioural responses, potent vasodilation, and plays a role 
in the contraction of many smooth muscles.79 Notably, one particular tachykinin, NKB, contains an 
ATCUN motif and binds Cu2+, forming an unusual complex.75 The complex consists of a 1:2 
Cu/NKB formation, with one molecule of copper binding to an N-terminal amine and an imidazole 
nitrogen from each molecule of NKB, illustrated in Fig. 3.75 This results in an unorthodox alteration 
of the peptides structure.80 Normally in other peptides, copper binds to an ATCUN motif, 
conforming to a 1:1 planar stoichiometry.81 Functionally the complex has been shown to not inhibit 
Figure 2- The ATCUN binding motif. The formation of the ATCUN motif requires a histidine in 
the third residue, a preceding residue, and a free N-terminus. Peptides containing an ATCUN 
motif that bind copper do so at their His residue, with the overall structural formation of the 
ATCUN peptide dictating interactions. Image used under creative commons license: CC BY-NC-
ND 3.0.  
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the NKB-mediated endocytosis of its cognate receptor NK3R.80 It was also observed that overall 
cellular copper concentrations increase when copper is delivered via the [Cu2+(NKB)2] complex, 
however, this does not tell us about copper’s intracellular fate.80 Interestingly, the tachykinin 
neuropeptide NKB, has been repeatedly implicated in playing a role in numerous neurological 
illnesses in common with copper including Alzheimer’s Disease and Schizophrenia, and therefore, 
further exploring the implications for the copper bound neurokinin complex on copper’s 
intracellular fate is warranted.  
Endocytosis 
1.3.1 Overview 
G protein-coupled receptors (GPCRs) are versatile signalling proteins that mediate complex cellular 
responses to ligands and neurotransmitters.82 Many GPCRs have been identified to exist in a 
multitude of functionally distinct conformations. For many GPCRs, binding of their endogenous 
ligand leads to conformational changes at their C-terminus, which promotes interactions with 
cytosolic proteins notably G protein-coupled receptor kinases (GRKs) and arrestins, and elicits a 
variety of signalling cascades.82  Once activated, many receptors undergo endocytosis, triggering a 
multitude of processes, such as sequestration of ligands, down regulation, and regulation of various 
signalling pathways.83 The process of receptor mediated endocytosis permits the active transport of 
large polar molecules into cells by binding to a specific receptor, activating it, and triggering 
envelopment of the ligand-receptor complex. This process is one way in which large molecules can 
pass the cell membrane. Endocytosis of plasma membrane proteins is often dependent of the 
recruitment of clathrin to the membrane. The formation of clathrin vesicles at the plasma membrane 
for endocytosis is a multi-step process, involving complexes of AP2 (adapter proteins) binding to 
oligomeric clathrin triskelions and the dynamin family of GTPases to catalyse budding (Fig. 3).84 
NBAR proteins (N-terminal Bin, Amphiphysin and Rvs proteins) curve the plasma membrane, with 
actin and regulatory elements providing structural support, allowing adapter proteins and clathrin to 
form a proteinaceous coat upon the forming vesicle.85 The co-ordination of clathrin assembly by 
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accessory proteins, allows the spontaneous formation of clathrin triskelions, resulting in 
development of polyhedral cages.84 Tyrosine-motif binding sites contained within adapter proteins 
allow for receptors to bind and allow for correct cargo recognition by the adapter complex.84  
Once within the cytosol, adenosine triphosphate (ATP)-dependent un-coating enzymes cleave 
bonds within the clathrin polyhedral cage, allowing rapid removal of the clathrin coat for reuse back 
at the membrane for the next round of endocytosis.84 In contrast, noteworthy are the emerging 
clathrin-independent pathways of endocytosis, such as the caveolar pathway and fluid-phase 
endocytic mechanism.87 These differ from traditional CME, as the internalisation of cargo and 
delivery to the early endosome can be via a different vesicular coating (caveolin) or via coating and 
dynamin independent tubular intermediates (known as CLICs) that originate from the plasma 
membrane.87 Also, the destination of these clathrin-independent pathways may differ, with some 
pathways first trafficking to other compartments, such as caveosomes or glycosyl 
Figure 3- Steps of Clathrin mediated endocytosis mediated by key constituents. (1) Adapter 
proteins are recruited to the plasma membrane. (2) Clathrin assembles and bind to adapter 
proteins. (3) Enlistment of dynamin to the assembly, with the tension between the proteins and 
the bound membrane causes invagination and forms the clathrin coated pit. (4) Dynamin gathers 
at the neck and budding occurs. (5) Endocytosis of the enveloped receptor (6) Once inside the 
cell, the clathrin assembly disassociates and subsequent intracellular fates occur.  
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phosphatidylinositol-anchored protein enriched early endosomal compartments.87 However, 
knowledge of these alternate pathways is very much in their infancy, with many mechanisms 
underlying formation, budding and intracellular fates unknown.87  
The induction of Clathrin-mediated endocytosis permits regulation of many CNS functions such as; 
receptor internalization, metal uptake, and synaptic transmission. Receptor internalisation is a 
mechanism by which receptors and their cargo can be delivered to specific intracellular destination 
organelles. In the CNS, receptor internalisation is used for the uptake of essential components and 
macromolecules into the nucleus where more complex processes, such as gene regulation 
occurs.88,89 However, the compositional properties of some of these elements inhibit direct entry to 
the nucleus, with some known to bind to soluble nuclear transport carriers and/or other nuclear-
destined proteins as a prerequisite to their own entry into the nucleus.89 In particular, GPCR 
proteins such as CXCR4, bind to a ferritin heavy chain once induced by the chemokine CXCL12, 
resulting in CME of both the ferritin heavy chain and receptor, concluding with nuclear 
translocation of the ferritin heavy chain.88 This demonstrates the idea that a metal that may have 
limited ability to traverse the nuclear membrane, can bind to a high affinity GPCR, undergo CME 
and enter the nucleus with the aid of nuclear transport proteins or a receptor, once induced by a 
ligand. This provides a complex, highly regulated mechanism by which uptake and receptor 
internalisation can occur via CME.  
Nuclear transportation of GPCRs is mostly dependent upon the presence of either monopartite or 
bipartite nuclear localization sequences, and act as a signalling mechanism for the recognition of 
cargo-laden proteins destined for the nucleus.89 These nuclear localisation sequences are identified 
by transport carrier proteins, such as importin α/β, which once bound, interact with the phe-gly 
motifs found on nucleoporins within the nuclear pore complex (NPC), permitting the bound protein 
to translocate inbound to the nucleus.89,90 In an NLS containing GPCR, activation of the tachykinin 
receptor-NK3R (neurokinin 3 receptor), results in translocation of the protein to the nucleus via the 
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importin β-mediated NPC.91 Upon entering the nucleus, the NK3R protein interacts with acetylated 
histones H4 and H3, triggering IP3 and the subsequent adenylate cyclase pathway, inducing 
chromatin remodelling.91,92  This illustrates that a NLS containing GPCR can undergo CME, 
translocate to the nucleus via an importin-mediated pathway, and have a purpose to be in the 
nucleus, that is, responding to the external cellular environment via nuclear-based gene regulation.  
1.3.2 The role of receptor mediated endocytosis in metal metabolism 
RME is a fundamental process to cells, required for the transport of larger molecules into cells that 
are unable to passively diffuse across the membrane. Typically, inorganic compounds or metals, 
due to their thermodynamics and kinetics require a regulated method for their uptake, although it is 
not conclusively understood.93 However, there is one metal for which RME is an established 
mechanism for its import and may provide insight into how cells may be exploiting this machinery 
to allow other metals to traverse membranes.   
An example of a very well characterised receptor-mediated metal uptake pathway, is that of Iron. 
The transferrin receptor is an essential mediator for the internalisation and regulation of cellular 
iron levels, essential for neuronal function. Basal synaptic transmission is reliant upon the uptake of 
iron for normal function.94 Studies have shown that in the pre-synaptic neuron, internalisation of the 
TfR enhances neurotransmitter release into the synapse, and administration of a clathrin-specific 
inhibitor resulted in upregulation of the glutamate receptor-AMPAR, provoking lethal epileptic 
seizures.94 This illustrates that the clathrin-specific internalisation of iron via the transferrin receptor 
pathway specifically, has a unique and important role in iron metabolism in the CNS, and is 
essential for preventing excitotoxicity. Excitotoxicity is an interesting symptom, as it has been 
implicated in many neuroinflammatory states, neurodegenerative and neurodevelopmental 
disorders.95,96,97,98 Coincidently, copper is implicated in having a possible neuroprotective role in 
excitotoxicity. As stated previously, copper was found to modulate the expression of dynamin and 
synapsin in hippocampal neurons, reducing presynaptic Ca2+ influx and dampening synaptic 
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activity.20 This further highlights the possible far reaching implications metal dysregulation may 
play in a huge array of CNS disorders.    
It has been previously established that the transferrin receptor mediates the uptake and subsequent 
intracellular release of iron via a pH dependent and clathrin-mediated pathway.99 Once the Fe2+-
bound transferrin, binds to the transferrin receptor (-TfR1), it triggers a cascade of events, including 
endocytosis of the entire complex.99 Some of these events include the initiation of clathrin coated 
pit formation, dynamin recruitment, budding and endocytosis of the complex, followed by 
compartmentalisation as membrane bound endosomes.99 Once in the intracellular space, the 
complex encounters a pH change which induces the release of free Fe3+, which is than reduced to 
Fe2+ by an oxidoreductase. Fe2+ continues its journey, exiting the endosome to be released into the 
free cytosol via the divalent metal transporter 1 (DMT1).99 The physiological significance of 
transporting Iron into the cell via receptor-mediated endocytosis is that it allows the flow of Fe2+ 
into the cell, change oxidation states in a controlled fashion, and releases it safely to be stored in 
ferritin or to be used as a co-factor for a multitude of proteins and enzymes, including aconitase, 
cytochromes, RNA reductase, and as heme for binding to vascular globulins.99 This mechanism 
demonstrates a highly sophisticated and regulated form for the effective uptake, storage and usage 
of a metal ion essential for cellular function.  
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Presently, this method of transitional metal cellular regulation has only been demonstrated for iron. 
However, it describes an established route that may be plausible for other essential metals, with this 
concept yet to be explored. The intake of iron highlights the possibility for the sequestration of 
receptor bound metals via endocytosis, and subsequent processing and release into the cytosol via a 
metal transporter or chaperone protein. This feasible mechanism is in agreement with current 
knowledge on the necessity for strict regulation within cells for the uptake, storage, and processing 
of metals in the cellular environment, as redox reactions and subsequent production of hydroxyl 
radicals, pose a significant threat to cell survival.  
1.3.3 Future Possibilities  
The current understanding of RME dynamics is incomplete and with partial knowledge currently 
explaining how copper gets into cells, the probability of RME possibly playing a part in copper 
metabolism is feasible. It has been established that NKB undergoes RME via NK3R, with the 
copper-NKB complex not inhibiting this uptake.80,100 It has previously been demonstrated that upon 
agonist stimulation by NKB, NK3R was taken up and positioned within perinuclear endosomes 
after 15 min at 37°C via transient β-arrestin 2 co-localisation.100 An endosomal route to the nucleus 
from the cell surface is often employed by GPCR’s that contain a NLS, for which NK3R meets this 
structural necessity.89,101 The presence of NK3R in the nucleus has been previously observed in the 
experimental data of some studies, however remains underexplored, with most current literature 
relying on neuron-specific expression or transfection into non-CNS cell lines.61, 102 Often, the 
accumulation of plasma membrane bound proteins in the nucleus is facilitated by an endosomal 
Figure 4- Iron mediated endocytosis of Transferrin and its cognate receptor. Iron is 
internalised by forming a complex with transferrin (Tf) and binding to the transferrin receptor 
(TfR). This process is mediated by clathrin, enveloping the metal-ligand-receptor complex and 
transporting it via endosomes. Iron is then released pumped out to the cytosol and the receptor 
and ligand is either recycled or degraded.  
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route, permitting the uptake of various transcriptional co-factors, regulatory elements, and proteins 
into the nucleus. As copper is necessary for life, it makes sense for cells to have a regulatory 
mechanism by which it can up or down regulate transcriptionally, proteins that are involved in 
copper metabolism.103 The presence of copper in the nucleus is well-established, but the 
mechanisms by which it gets there remain unexplained. 
Whether a metal may hitchhike wholly to the nucleus via ligand-induced RME of NK3R is 
currently unknown. However, as previously stipulated, this endocytic mechanism is not completely 
unheard of, as it is a well-established mechanism for Iron uptake via Transferrin and its receptor 
TfR1, although iron taken up by this method is not trafficked to the nucleus. Currently, most metal-
receptor characterisations have focused on direct binding of a metal to a receptor. An example of 
this is zinc, where it binds directly to post synaptic dopaminergic receptors upon presynaptic 
release, modulating neuronal activity.104 Interestingly, one study identified that NK3R structurally 
contains a di-histidine Zn2+ site, which permits Zn2+ to directly bind to the receptor, acting as an 
agonist, inducing a conformational change.105 This parallels with recent intriguing data about 
CTR1, a copper transporter protein, where recent studies postulate the possibility that reduction of 
Cu2+ to Cu1+ can occur in the absence of reductases, and is conducted by the receptor itself 
structurally.106 The study synthesised high affinity peptides with an ATCUN binding motif, binding 
Cu2+ and CTR1, and discovered an adjacent di-histidine site that served as a high affinity Cu1+ 
binding site on the receptor. Variation in the distance between the synthesised ATCUN and di-
histidine site, revealed variability in the availability of reduced copper. This introduces an 
interesting paradigm, if CTR1 displays this ability (although synthetically derived) with structurally 
similar circumstances to the native NK3R, could this be possibly occurring for NK3R with the 
endogenous NKB peptide?  The binding of copper to NKB is indeed intriguing, however it remains 
unknown if the copper-NKB complex is capable of exploiting the structural availability of the di-
histidine site in NK3R, serving as a possible alternate entry point for reduced copper to increase 
nuclear copper concentrations. 
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1.3.4 Integration of RME in treating metal-based Neurocognitive disorders 
An exciting opportunity for the development of therapeutics capable of effective drug delivery is 
the ability to utilise receptor mediated endocytosis.107 As a naturally occurring mechanism within 
cells, intracellular transport and cellular specific uptake of molecules via receptor induced 
endosomal compartmentalisation, presents an exciting opportunity yet to be exploited by 
conventional pharmaceuticals. However, a major roadblock to this opportunity is the current 
understanding of receptor mediated endocytosis. Limitations to ways of managing many factors, 
from intracellular compartmentalisation, bioavailability, crossing membranes, oligomerization, 
diversity and subtypes of one cell type, nuclear compartmentalisation, transcription regulation and 
downregulation of receptors, and the heterogeneity of receptor populations within a given cell, 
have seen many pharmaceuticals targeting receptors at the cell membrane not progress through 
clinical trials.  
The main issue with current pharmaceutical developments is that many rely upon the passive 
diffusion of low molecular weight compounds that easily penetrate across membranes, but lack 
specificity for affecting intracellular compartment-specific interactions.108 This approach relies 
upon a higher dosage to essentially saturate cells and tissues, until a therapeutic benefit is realised 
without presenting significant toxicity or side effects.108 As a result of this non-specificity, there is 
a greater risk of approaching concentrations that evoke side effects or lack reliable therapeutic 
benefit. Another issue for the pharmaceutical industry is the reliance upon the development of high 
molecular weight compounds with a charge to interact with a receptor on the cell surface.108 This 
prevents membrane penetration and passive diffusion, and lacks the ability to interfere with 
receptor endosomal compartmentalisation, nuclear interaction and regulation, and recycling back to 
the membrane.108 As a result, this particular model may explain why many receptors with either 
established receptor-mediated endocytic pathways or indeed those suspected of having such 
pathways have mixed results in clinical trials.  
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The challenge is great for pharmaceutical development. Progress for the greater characterisation of 
RME pathways, endosomal compartmentalisation, nuclear trafficking, and receptor recycling 
machinery within receptors suspected of undertaking such processes is required. This clarification 
in characterisation may allow pharmaceutical development of molecules with greater specificity 
targeting such processes, resulting in greater outcomes at clinical trials and with lower dosages. 
Also, with clarification on RME pathways comes the opportunity to exploit the machinery as a new 
method of drug delivery to a specific compartment within a cell, reducing the risk of toxicity. This 
method of drug delivery has been implicated as a possible avenue for the development for 
antibody-based conjugates of receptors to exploit receptor-mediated endocytosis for effective 
internalisation and delivery to compartments.108  
Currently, in the case of neurocognitive disorders such as Schizophrenia, NK3R antagonists 
Talnetant and the non-peptide Osanetant, initial clinical trials reported success, but mixed results at 
a later stage two trial.109 This led to the shelving of these two promising drugs for the treatment of 
Schizophrenia. The NK3 receptor is suspected to undergo trafficking via a receptor-mediated 
pathway, although further evidence and clarification is required.  Many other analogous 
compounds have been synthesised to alter NK3R expression, however such as in the case for many 
other pharmaceuticals, had mixed effectiveness, being only able to inhibit NK3R at the membrane 
but not nuclear distribution.110   
Alternatively, the RME of Iron via the transferrin pathway has recently been exploited for the 
therapeutic development of a highly selective method to deliver therapeutic agents to cancer cells. 
One study established that TfR-1 could be used to transport doxorubicin to cancer cells that were 
overexpressing TfR-1 in a highly selective fashion.111 In another study, it focused on a dual action 
of drug and imaging agent delivery. In the study mentioned, MCF-7 breast cancer cells were shown 
to have higher expression of ferritin specific receptors, and greater uptake of a MRI contrast dye, 
via parallel delivery of the contrast dye, and the therapeutic agent being tested for its ability to 
reduce cancer cell proliferation, curcumin.112 This exhibits a method by which the uptake of a 
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metal based nanoparticle can exploit the endocytic mechanism of a known metal-conjugate-
receptor complex (transferrin mediated), internalises via RME, enabling a highly specific delivery 
to predict and monitor therapeutic responses to a drug in real time with a MRI contrast dye. This is 
indeed an exciting concept yet to be fully exploited in diagnostics and pharmaceutical 
development. If a pathway of RME is indeed true for other metals, then it may have potential 
applications for effective non-invasive drug delivery and monitoring of hard to treat brain cancers 
via brain-specific metalloproteins, and of ROS-induced damage in neurological disease.  
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Project Aims 
 
1. To identify NK3R localisation and distribution in subcellular compartments of astrocytes 
2. To characterise the nuclear NK3R protein concentration after activation by NKB and 
[Cu2+(NKB)2]. 
3. To quantify copper concentrations in the nucleus of astrocytes and neurons in response to 
NK3R trafficking induced by [Cu2+(NKB)2]. 
4. To identify the initial mechanism underlying NK3R nuclear trafficking 
5. To identify and compare NK3R expression in neurons to astrocytes 
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Chapter Two: Materials and Methods 
 
  
Unless specified all other chemicals and materials were obtained from Sigma Aldrich (Castle Hill, 
Sydney, Australia). All water used was Milli-Q purified (18 MΩ) and essentially copper free as 
determined by inductively coupled plasma-mass spectrometry.  
2.1 Cell culturing   
 The 1321N1 human astrocytoma and SH-SY5Y human neurobalstoma immortal cell lines were 
chosen for this study. 1321N1 astrocytes were used as they have previously been shown to 
endogenously express the NK3 receptor and the receptor was shown to be functional (i.e. triggered 
intracellular calcium release) when cells were exposed to exogenous neurokinin B. The glial lineage 
of these cells was shown by the expression of the astrocyte specific marker protein glial fibrillary 
acidic protein.75 The use of SH-SY5Y human neuroblastoma cells allows direct contrast of NK3R 
human specific protein expression with the expression exhibited by 1321N1 human astrocytomas. 
However, as both lines chosen are human immortal cancer cell lines there is an increased risk of 
genetic drift over subsequent passages over time. To minimise the risk of this, throughout this work 
cells were discarded at passage 20 or every two months.  
1321N1 Astrocytes were cultured in supplemented DMEM, consisting of high glucose DMEM 
(Gibco), 10% FCS (foetal calf serum, Gibco), penicillin / streptomycin at a concentration of 5 
units/mL, and 5 μg/mL respectively. SH-SY5Y cells were cultured in DMEM/F12 Ham (With L-
glutamine, 15 mM HEPES, and sodium bicarbonate) supplemented with 10% FCS, and 1% NEAA, 
penicillin / streptomyacin at a concentration of 5 units/mL, and 5 μg/mL respectively. For copper 
depleted experiments, cells were incubated prior to and during treatment in a chelex treated copper-
free incubation buffer (pH7.54, 10mM HEPES, 130mM NaCl, 4.7mM KCl, 1.2mM MgSO4, 
1.2mM NaH2PO4, 11.5mM Glucose). All cultured cells were incubated at 37 °C in a CO2 
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humidified incubator set at 5% CO2, with cells passaged regularly at approximately 80% 
confluency.  
2.2 Fractionation   
For fractionation, cells were grown in 6 well plates, with each experiment repeated 3 times and 
randomised by growth and fractionation occurring on different days from different passages. 
Nuclear/Cytosolic fractionation was performed using a Biovision fractionation kit (Biovision 
#K266-25Nuclear/Cytosol Fractionation kit, Sapphire Biosciences) following the provided 
manufacturers protocol. BCA Protein Assays were conducted after fractionation on all samples to 
determine protein concentration, following manufacturers procedure (Cat no PIE23227, 
Thermofischer, Castle Hill, Aust). All generated fractions were stored at -80ºC until further use. 
Whole cell fractionation was conducted using a chelex treated RIPA buffer (150 mM sodium 
chloride, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS (sodium dodecyl sulfate), 50 mM 
TrisHCL, pH 8.0, and milliQ water). Cells at a density of 2x106 were collected and pelleted 
following treatment (see 2.2.4 Treatments), then suspended in 200l of RIPA buffer, with 
vortexing, incubations on ice intervals, and centrifugation mirroring the nuclear/cytosolic 
fractionation protocol for consistency. The ability of the fractionation protocol to generate pure 
fractions was determined by western blotting for the cytoplasmic localised protein, ferroportin 
(IREG).  
2.3 Western Blots  
Western blots were employed to confirm purity of generated fractions, verify that subcellular 
fractions contained the protein of interest (NK3R), at what molecular weights, and validate the 
fractionation procedures employed overall. The effective production of fractions permitted the 
subsequent quantitative analysis of metal and protein concentrations, interactions before and after 
treatment, and correlations with localisations. The markers employed for this study, IREG, and 
NK1R, were chosen for their usefulness as cytosolic marker proteins, in conjunction with DNA 
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detection via agarose gel electrophoresis as a nuclear marker. This approach allowed appropriate 
evaluation of purity based upon comparison of contents with known localisations.  IREG (Iron 
regulatory protein 1 or Ferroportin 1), is a transmembrane protein found in the plasma membrane of 
all cells. This protein is imperative for the regulated movement of iron out of cells.116 NK1R 
(Neurokinin 1 Receptor protein), is mostly a monomeric G-protein coupled receptor that resides on 
the cell surface and upon activation, is not trafficked to the nucleus..117  
Western blots were performed on nuclear, cytosolic, and whole cell lysates of 1321N1 cells devoid of 
any treatment and incubated in media, to reflect the NK3R and marker protein molecular weights that 
would be present in a homeostatic cellular state. Fractions obtained underwent denaturation at 80°C 
in a PCR thermocycler, followed by confirmation of presence or absence of DNA via DNA gel 
electrophoresis using a 1% agarose gel. The presence of DNA was determined by visualisation of 
DNA bound Syber-green. Subsequently, fractions were then subjected to immunoblotting, with 
approximately 20 g of protein from each sample loaded into a 12% sodium dodecyl sulfate 
polyacrylamide gel (SDS-PAGE) followed by transfer to a nitrocellulose membrane (Bio-Rad Turbo-
Blot).  Following blocking of the membrane for 1hr at 4°C in 5% skim milk dissolved in 0.5% tween 
20 Tris buffered saline (TBST), membranes were incubated in either IREG (1/2000), NK1R 
(1/5000), or NK3R (1/2000) antibodies (Sigma Aldrich) overnight at 4ºC. Following incubation, 
membranes were washed with TBST 3 times, and incubated in an HRP-conjugated secondary 
antibody for 1 hour. At least five washes in TBST were undertaken to remove excess secondary 
antibody, then the membrane was exposed to the chemiluminescence substrate (Premium 
Westernsure ECL Licor) and the resulting chemiluminescence was detected using a C-Digit 
chemiluminescence scanner (Licor). 
2.4 Cell Treatments  
A stock (50mM) solution of Cu2+ was prepared as CuCl2·2H2O in water and diluted further to a 
50µM working solution. Neurokinin B (DMHDFFVGLM-NH2) was synthesised by Synpeptide 
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(Shanghai, China). The NKB peptide was dissolved in 100% DMSO, and subsequent working 
dilutions made. The concentration of the NKB was determined by UV absorption at 259 nm and 
using the extinction coefficient of phenylalanine (190 M−1 cm−1 × number of phenylalanines).  
Once cells were plated and ready for treatment, cells were washed with 1x PBS three times, and 
cells were incubated in either media or copper-free buffer, depending upon the conditions required. 
Cells were incubated for 20 min in their respective test environment prior to undergoing treatment 
as per Fig. 5. Cells that required clathrin inhibition were incubated in a 25M working solution of 
Pitstop 2 (Abcam, Sigma Aldrich, Cat no SML1169), with their respective environmental condition, 
containing 0.3325% DMSO for 10 minutes at 37C, with no precipitate observed. Following 
incubation, the working solution was discarded, cells were washed 3 times with 1x PBS, then either 
media or copper-free buffer was added, followed by treatment. For all clathrin inhibited-in media 
treated cells, media preparation deviated to eliminate any FBS, as incubation in FBS is known to 
reinstate Clathrin-mediated endocytosis and would counteract the clathrin inhibitory effect of 
Pitstop 2.118 Once cells were exposed to their treatment of choice, cells were incubated for 2hrs at 
37C with 5% CO2 perfusion. Following treatment incubation, cells were either fractionated 
according to Chapter 2.2, or prepared for confocal microscopy according to Chapter 2.6 if cells 
were grown on coverslips.   
Treatment incubation time was determined following an extensive literature review and preliminary 
testing of generated lysates for their protein concentrations at 20 min, 1hr, and 2hr intervals, 
followed by testing of copper concentrations via Flame Atomic Absorption Spectroscopy. Our 
protocol optimisation indicated that copper uptake and protein concentration was maximal at the 
2hr interval. 
 
 
55  
  
 
 
 
 
Figure 5- Flow chart of treatments to astrocyte populations. In total, 28 nuclear, 28 cytosolic 
and 20 Whole cell lysates were generated, and replicated 3 times, producing a total of 228 
fractions. Whole cell lysates were used as a control measure to ensure intracellular lysate 
retrieval was consistent with known whole cell data and to exclude the existence of any method-
specific artefacts. **Cells that were clathrin inhibited in media were devoid of FBS in 
comparison to non-clathrin inhibited populations. *** Treatment schedule varied for the copper-
NKB populations destined for confocal imaging, with 1M instead of 3M administered to allow 
a more linear visual intensity comparative analysis.  
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2.5 Inductively Coupled Plasma-Mass Spectrometry  
ICP-MS is the most sensitive analytical technique for metal analysis presently available.119 Copper 
concentrations in cell fractions were assessed by Inductively Coupled Plasma-Mass Spectrometry 
(ICP-MS, Perkin Elmer NexIon300). ICP-MS works by ionizing a sample in plasma, then using a 
mass spectrometer for separation and quantification of ions. This is based upon mass-to-charge ratio 
identification of ions and the ion signalling being proportionate to the concentration of the ions.120  
Copper concentrations present in all generated fractions were determined using a Perkin Elmer 
NexIon 300 ICP-MS fitted with a nebuliser for sample aspiration. Instrument parameters were 
calibrated and optimised using both manufacturer supplied solutions and prepared copper solutions. 
Copper standards were prepared from a 50mM CuCl2 stock solution and were compared to a 
commercially available copper standard (titrated with EDTA) via ICP-MS, with no significant 
variation in copper counts detected.    
Due to the relatively low yield of fractions generated (100L), manual sampling to the ICP-MS was 
employed, with fractions prepared via a ¼ dilution in MilliQ H2O and 1% HNO3. Prepared copper 
standards were run prior to each batch of lysates with a range of 0.05M to 3M Cu2+ (3.173 ppb to 
190.638 ppb). 2% HNO3 washes were employed between each sample run and additional 4% 
HNO3 washes done as required, to minimise any possible baseline drift. Peak intensity (counts/s) 
were obtained, with a copper standard curve (counts/s of peak copper intensity vs concentration of 
Cu2+) generated and used to determine copper concentration of lysates in M. All copper standard 
curves had a R2 value greater than 0.989. Lysate results were then normalised by deducting the 
milliQ water reading, accounted for the dilution factor in sample preparation, and standardised to 
M Cu2+/mg of protein.    
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2.6 Confocal Microscopy and Spectral Phasor Analysis 
Various microscopy techniques allow for the examination of intracellular structures and 
compartments in a fixed state. Confocal microscopy works by a laser emitting light at specified 
wavelengths, with the light passing into the microscopes pinhole that is conjugated to the focal 
point of the lens, hitting the sample, then out to a detector that allows computational reconstructions 
providing optical sectioning and 3D remodelling of cells.121  
Confocal microscopy was used to qualitatively analyse the localisation of endogenous NK3R, 
copper activated, apo-neurokinin B activated, and copper-NKB complex activated NK3Rs within 
cells.  Cells were prepared for imaging experiments, grown in 6 well plates (106) with inserted 
sterile glass coverslips, till approximately 60% confluency. Once grown, cells were treated (see 
2.2.4), washed three times in PBS, fixed in 4% formalin solution for 20 mins, permeabilised using a 
0.5% triton x-100 solution for 15 mins, then blocked in 1% BSA for 1 hr at room temperature. 
Following blocking, cells were incubated in primary NK3R antibody overnight at 4OC, then 
Figure 6- Standardisation of copper concentrations using a copper calibration curve. One of 
the many copper standard curves produced using prepared standards. Small fluctuations seen at 
concentrations less than 1M are expected as concentrations get closer to and surpass the 
minimum detection range limit for ICP-MS, which lays at approximately 10ppb.   
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following three PBS washes, were incubated in Cy-568 labelled secondary antibody for 1hr at room 
temperature, covered in foil. Coverslips were then inverted and mounted onto Antifade treated 
slides (ProLong™ Gold Antifade, Invitrogen, Thermofischer Scientific), and edges were sealed 
using nail polish. Detection was performed on a Leica Confocal Scanner Spectro-Photometer 5 
inverted laser scanning confocal microscope (Leica Microsystems, Germany). The confocal 
microscope was setup to use a 63 × 1.4 NA water objective, an argon laser at 20% capacity and 613 
nm laser at 9% power.  The frame resolution was set to 512x512 pixels, with the single channel 
photon multiplier tube detector set between 567 and 625 nm.  
An xyz scan was undertaken at 400Hz speed, with the emission bandwith set between 567 nm and 
700 nm. A scan was undertaken through the z plane, scanning through 32 detection stops with a 
stripesize of 5 nm. All samples were later analysed using the SimFCS software package (available 
from www.lfd.uci.edu).  To separate the fluorescent-NK3R signal, spectral phasor analysis was 
performed. Spectral phasor analysis is based upon the Fourier transformation of emitted spectra 
obtained from each pixel in the hyperspectral image generated from the 32 channel lambda scan. 
The spectral phasor transformation allows the construction of a polar plot, with each spot 
representative of one pixel. The emission spectra present at each pixel is then further transformed 
into two parameters called G and S (representative of amplitude and phase), which is plotted in a 
quadrant plot, that is, the actual spectral phasor plot.122,123 It is with these generated plots that 
graphical comparisons between the various treatments may reveal shifts in spectra that can be 
associated with changes in the biochemical intracellular microenvironment. The position of the 
phasor coordinates on the plot is representative of the emission spectra and thus, if there is a shift in 
wavelength, the coordinates will differ in polarity. Differences within microenvironments that 
contribute to differences in spectra include pH, ion concentration, protein binding, and interactions 
122, 123  
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2.7 Clathrin Inhibition 
Clathrin plays a significant role in endocytosis. A known component in vesicle formation, the 
internalisation of many GPCRs have been found to be clathrin-mediated. In order to identify if the 
internalisation of the NK3R protein is clathrin-mediated, astrocytes incubated in media and in 
copper-free buffer were treated with N-[5-[(4-Bromophenyl)methylene]-4,5-dihydro-4-oxo-2-
thiazolyl]-1-naphthalenesulfonamide (PitStop 2, Sigma-Aldrich), an established clathrin inhibitor. 
Furthermore, cells were also subjected to the various treatments (Fig. 5 in Chapter 2.4) following 
clathrin inhibition, to identify any copper-induced variability. Pitstop 2 is a highly potent selective 
inhibitior of CME, blocking access to clathrin’s amino terminal within the heavy chain, inhibiting 
the interaction between amphiphysin and the clathrin terminal domain.124     
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Chapter Three: NK3R is found in the nucleus and the 
cytoplasm in various conformations.  
 
 
3.1 Introduction  
The spatial distribution and structural conformations of GPCRs, both at the cellular level and 
systemically can provide clues to their functionality.101 GPCRs often traffic from the plasma 
membrane to intracellular locations, including the nucleus. The location of NK3R in the cell is not 
entirely clear, but previous work has identified the receptor at the plasma membrane and in the 
nucleus. GPCRs often undergo endocytosis after activation, but the presence of the receptor in the 
nucleus is a relatively unusual feature. Some work has suggested that NK3R in the nucleus is not 
truncated, which is quite rare as most nuclear GPCRs are truncated prior to entry.110 Further, more 
variability in protein conformations that may be present in different subcellular compartments has 
not been explored.  
Variability in the conformational states of a receptor influences the intracellular response that is 
normally highly specific, selective and dependent upon the stimuli acting upon the receptor.101 This 
concept demonstrates how important the elucidation of receptor expression is to understand 
subsequent signalling pathways and spatial-specific functionality of a protein. Further diversifying 
potential GPCR function, possible multimerization will be explored, as many other Rhodopsin 
based GPCRs are known to form homodimers and heterodimers.125 Although such interactions are 
transient, some receptors have been identified as existing in a stable multimeric configuration, thus 
still warranting exploration.126 Overall, the exploration of NK3R expression within the nucleus and 
the cytosol forms the initial step in ultimately understanding NK3R function and, potentially, its 
role within the nucleus.    
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3.2 Results and discussion  
In order to ascertain spatial distribution of endogenous NK3R intracellularly in non-transfected 
cells, we initially compared immunohistochemical detection of the retrieved fractions. In human 
astrocytes, NK3R was consistently expressed in both nuclear and cytosolic fractions (Fig. 7).   
 
 
To confirm that the NK3R expression was due to the receptor being translocated into the nucleus 
and not from cytoplasmic contamination, each sample was immunoblotted for ferroportin (a plasma 
membrane/cytosolic iron exporter) and NK1R. The nuclear samples were found to be devoid of any 
expression, but bands corresponding to the predicted molecular weight of IREG and NK1R were 
observed in the cytosolic fraction (Fig. 7). These results correlated with previous literature, where 
immunoblotting for ferroportin and confocal microscopy for NK1R demonstrated their expression 
Figure 7- Western Blot of endogenous NK3R in Astrocytes. IREG and NK1R was used as control 
markers and was detected at 40 kDa and 60 kDa respectively (panels on right). NK3R (left panel) 
was detected in both nuclear and cytosolic lysates at approximately 250 kDa, with a distinct 
nuclear band at 60 kDa, and numerous other faint bands detected in the cytosolic and whole cell 
fractions. The designation of ‘blank’ to a lane means that lane was not loaded with any sample. 
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was mainly restricted to the cytosol and peripheral membranes.116,117 These controls show that the 
fractionation protocol was effective in generating pure cytoplasmic and nuclear fractions. We are 
therefore confident in predicting that the accumulation of nuclear NK3R protein noted in Fig. 7 is 
due to the presence of the receptor to the nucleus, and not from cytoplasmic contamination of the 
nuclear lysates. 
In contrast to the NK1R control, the expression of the NK3R protein was detected within both 
cytosolic and nuclear fractions and was present at multiple discrete molecular weights. In Fig. 7, 
bands are detected in both cytosolic and nuclear fractions, with both monomeric protein (~50 kDa) 
and a higher molecular weight (~250 kDa) species present in the nucleus. In the cytosol, the 
monomeric protein is notably absent, but the higher order band and various other bands are present.   
This is indeed interesting, as SDS-PAGE electrophoresis is known to denature proteins, disrupting 
oligomerization and protein structure.127 Our results show that despite the presence of SDS and 
heating the samples prior to electrophoresis, the NK3R protein resists denaturation, with multimeric 
species present in both the nucleus and the cytosol. At present, the identity of these various other 
NK3R species is completely unknown. However, it is well known that many GPCRs can form 
multimers and can have many post translational modifications, such as glycosylation and 
phosphorylation.128,129 Indeed, some GPCRs are known to remain in a dimeric state all the time, 
while others are known to cycle between their monomeric and dimeric states dependent upon ligand 
regulation130. Each of these multimer states and modifications provide clues to the protein’s 
destination within the cell, as the structural diversity of GPCRs can result in different functional 
outcomes.128  
Although the additional bands detected for NK3R are unknown, it is not unusual for a GPCR to 
have both monomeric and multimeric subpopulations within a cell. Consistent with the whole cell 
lysate (Fig. 7), the results illustrate that although a different fractionation protocol was implemented 
for the whole cell fractionation, similar bands to those detected within the cytosolic and nuclear 
fractions were present. This confirms that these various species are consistent under SDS denaturing 
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conditions, regardless of the fractionation protocol employed. The lack of a monomeric band in the 
whole cell lysate is difficult to reconcile, however, it is possible that the conditions required for 
preparation of the lysate (RIPA buffer) did not adequately cleave the nuclear membrane to release 
monomeric NK3R. This requires further investigation, because monomeric and high molecular 
weight species have been observed previously for whole cell lysates 1321N1 astrocytes. Indeed, the 
various bands detected for NK3R have been previously depicted within literature, although these 
often remain unexplained.131 It is unlikely that the high molecular weight species detected is an 
artefact of any fractionation procedure.  
Previous studies may provide clues as to what the identity of the additional molecular weights for 
NK3R may be. In one study, the presence of numerous bands for NK3R at apparent molecular 
weights greater than the monomeric protein led them to postulate that NK3R may be 
glycosylated.132 However, there was little evidence provided to support such a hypothesis as their 
immunoprecipitation results showed a complex with histones with a molecular weight of about 100 
kDa, which better supported their other hypothesis about NK3R being in tight association with 
various other cytosolic and nuclear proteins.132   
Many GPCRs are known to form multimers, diversifying mechanisms of function and down 
signalling. The formation of oligomers enables localised receptor populations to amplify their signal 
and activate alternate signalling complexes.101 Furthermore, it is well known that some of these 
multimers can form distinct functional units in their own right, with some neuropeptide and 
monoamine receptors forming heteromers, and others such as dopamine D2 forming homodimers.101 
Because our Western blot results show that these higher molecular weight bands are quite dense and 
in tight association with little smearing, we hypothesise that bands greater than the monomeric 
weight may be various multimers of NK3R protein rather than post-translational modifications or 
other transient interactions. Given the monomeric molecular weight of 60 kDa, the the higher 
molecular weight could be a homopentamer.    
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In agreement with the immunoblotting results, immunofluorescence analysis of NK3R intracellular 
localisation (Fig.8) revealed that in a homeostatic environment, NK3R is endogenously distributed 
throughout the cell.  
 
  
  
 
 
 
The presence of a punctuate pattern in certain areas of the cell is indicative of co-localisation of 
NK3R. Receptor co-localisation is a common phenomenon within cells, with many occurring at the 
cell membrane as part of the endocytic process. Co-localisations of receptors has previously been 
shown to be present in both clathrin-mediated, caveolin-mediated, and lipid raft induced 
endocytosis.133,134,135 The distinct dynamics mediated by each of these methods of endocytosis is 
discussed in detail in many studies.136,137,138 However, co-localisation that is present in the nucleus 
is an interesting occurrence. Previously, one study identified spatiotemporally two receptors that co-
localised with each other in the nucleus, with results indicative of a coordinated action of the two 
corticoid receptors on gene expression.139 This illustrates that any co-localisation of receptors 
within the nucleus, in contrast to the endocytic membrane bound receptor populations, may play a 
distinct role in the nucleus that is spatio-temporally specific. Considering that NK3R protein is 
present within the majority of nuclear subdomains, with concentrated areas of localisation within 
Figure 8- Endogenous NK3R cellular distribution under normal homeostatic conditions. 
Confocal and brightfield images of 1321N1 astrocytes in media untreated. NK3R is distributed in 
an even fashion across the cell, including all areas within the nucleus. Notably, some areas 
around the periphery and in the nucleus display a punctuate pattern, indicating hotspots of 
NK3R co-localisation. 
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cajal bodies and speckles when compared to the brightfield image (Fig. 8 far right), it remains to be 
demonstrated what this means for the nucleus functionally.  
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Chapter Four: Ligand-induced receptor mediated endocytosis 
increases nuclear copper 
 
 
4.1 Introduction 
A key concept in metal accumulation is the dynamics between metals and the proteins that mediate 
their movement within cells. It is well known that cells employ elaborate mechanisms to protect the 
cytoplasm from metal toxicity.140 However, protein accumulation in the cytosol is not sufficient 
enough to guarantee activity or nuclear translocation of a metal, but rather, the ability of a metal to 
exploit the peptide sequence that permits the targeted uptake.141 Additionally, protein-metal 
interactions must be able to overcome the obstacle of endosomal trapping, a common feature seen 
in NLS containing peptides.141   
NK3R is identified as a GPCR that undergoes nuclear trafficking and its cognate ligand is known to 
bind copper ions but the relationship between them and the effect of copper on cellular trafficking is 
not clear. Furthermore, recent studies indicate a more involved role for endocytosis on metal 
regulation than previously thought.142 Thus, identifying the relationship between NK3R and copper 
trafficking can contribute to the current body of evidence on the effect that receptor mediated 
endocytosis has on metal accumulation and localisation.  
4.2 Results and Discussion 
4.2.1 Copper-bound Neurokinin B induces endocytosis and nuclear localisation of NK3R 
Here we assessed the effect of copper-bound neurokinin B, a tachykinin neuropeptide known to 
mediate receptor uptake of NK3R. As a comparison, cells were incubated with copper delivered as 
CuCl2. Uptake of copper in this form is known to be mostly mediated by CTR1 and, to a lesser 
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extent, DMT1, and therefore serves as a positive control in a dose-response manner.28,32 This allows 
us to distinguish between effects on receptor localisation vs. the initial copper-delivery mechanism 
employed. 
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 Upon activation of NK3R by its cognate ligand neurokinin B, there is greater localisation of NK3R 
intracellularly, however it is evidently evenly distributed. This is in agreement with previous studies 
showing the activation and endocytosis of NK3R by NKB.80, 143  
In the copper treated cells, cell morphology deviates, with greater rounding of cell bodies, less NK3R 
in the cytosol and nuclear distributions of NK3R taking on a more punctuate pattern. This is consistent 
with the ability of excessive copper to induce oxidative stress, which causes plasma membrane 
blebbing, and eventual apoptosis.144 Although the dosages of copper administered are similar to 
previously identified endogenous copper concentrations found within the brain145, our results 
illustrate that even subtle deviations or increases in cellular copper exposure have a profound effect 
on cell morphology and protein distribution. It is known that free Cu2+ is reduced to Cu+ by reductases 
and taken up mostly via Ctr1 and DMT mediated pathways.28,32 However, it is unknown how can the 
reduction and uptake of copper via this already well characterised pathway can interact and change 
both nuclear and cytosolic NK3R cellular distribution. Nevertheless, it is possible to speculate that 
the metal-binding di-histidine site on the extracellular face of NK3R coordinates copper when 
delivered as CuCl2 and activates the receptor. This would account for the observed changes in NK3R 
cellular localisation in Fig. 9. 
Previously, the only protein shown to be able to transport copper to  the nucleus is Atox1, however it 
was demonstrated in mouse embryonic fibroblasts by measurement of the 64Cu isotope administered, 
thus not identifying the oxidative state of the nuclear copper present.146 In addition, the interaction 
between free copper and Atox1 bears many similarities to our results observed for NK3R. Copper is 
Figure 9- Cellular localisation of NK3R in Astrocytes in response to free copper and 
[Cu
2+
(NKB)
2
]. (A) Under homeostatic conditions, activation of the NK3R under various 
treatments are illustrated with (B) showing results when cells are starved of copper, with notable 
deviations in NK3R distribution, with the majority of NK3R in all treatments residing in the 
nucleus in comparison to the homeostatic conditions.  
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known to induce translocation of Atox1 to the nucleus in a manner parallel to the copper induced 
nuclear translocation seen in Fig. 9. However, whether copper remains bound to any protein 
throughout its journey to the nucleus is unknown.  
Because Atox1 is well known as a copper transporter, delivering free copper to ATP7A and ATP7B 
destined for the trans-Golgi network, it is possible that free copper in the cytosol is trafficked to the 
trans-Golgi, disassociates from Atox1 and transferred to ATP7A. Other post translationally modified 
Atox1 proteins are activated, trafficking to the nucleus to later bind to nuclear copper. This hypothesis 
would agree with other studies that identified the binding of Atox1 to the Atox1 Response Elements 
at the SOD3 promoter in a copper-dependent manner, increases SOD3 activity only in the presence 
of both TGN-targeted and nuclear targeted Atox1 proteins.146 When TGN-targeted Atox1 protein 
expression was knocked out, SOD3 activity did not increase even with nuclear Atox1 bound to 
nuclear copper present.146 This demonstrates that there were two independent subpopulations of 
Atox1 protein, one that translocates to the nucleus and the other to the TGN, with both populations 
induced by copper and required along with the presence of copper required to exert transcriptional 
regulatory activity. This model may be applicable to the greater nuclear translocation of NK3R from 
the cytosol, and lack of receptor activation and internalisation to the cytosol due to the shortage of 
plasma membrane-bound receptor activation in response to free copper we observed. However, 
further characterisation is required to discern if and when copper is bound to either or both Atox1 and 
NK3R proteins upon copper induced translocation to the nucleus, thus providing a vital link between 
protein translocation and the delivery of free copper to the nucleus, which so far remains elusive.  
Interestingly, the redistribution of NK3R localisation to translocate to the nucleus in response to 
copper only treatment, devoid of the cognate ligand NKB is unique. When copper is transferred to 
ATPases, it is loaded into synaptic vesicles and released as Cu+. Cu+ is then available to easily bind 
to methionine and cysteine amino acids on receptors, causing a structural change similar in effect to 
a disulphide bond. It is already established that receptor activity is modulated by the redox state of 
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cysteines.147,148 Thus, this method of receptor activation may be applicable for NK3R, as it contains 
a native di-histidine zinc binding site as described above, that can bind copper, and may bind the 
available copper in a similar manner, activating and mobilising it to the nucleus.149  
In contrast, when our cells were exposed to [Cu
2+
(NKB)
2
], receptor distribution went from being 
uniform to punctuate, with areas of dense localisation present in the nucleus. Overall, [Cu
2+
(NKB)
2
] 
treated cellular populations had greater receptor mobilisation, nuclear localisation (but notably absent 
in nucleoli), increases in density, co-localisation, and fluorescence emission than all other treatments 
administered.  The increase in emission is completely unaccounted for, as Cu2+ is known for its static 
quenching of fluorescence. However, we can speculate that the metal-ligand complex has possibly 
induced a pH dependent shift in spectra by affecting the interaction and subsequent emission 
properties of the conjugated fluorophore. Overall, this illustrates a distinct difference in receptor 
trafficking that is induced by the ligand bound copper. In Fig. 9, Apo-NKB results in receptor 
activation, although minor in effect compared to the [Cu
2+
(NKB)
2
] complex. Because the nuclear 
distribution of NKB induced NK3R does not deviate significantly from our untreated endogenous 
cellular distribution, we can conclude that receptor activation by [Cu
2+
(NKB)
2
] mobilises a distinct 
cellular internalisation pathway to that of NKB.      
This presents an interesting paradigm, that is, that the cognate ligand of the receptor induces receptor 
activation and internalisation, resulting in an even cellular distribution, while copper-peptide induced 
receptor activation mobilises a significant subset of receptors to co-localise and translocate to the 
nucleus. In parallel with previously identified ATOX1 activation, numerous receptor subpopulations 
co-exist, with the activation of total or select populations resulting in different outcomes for the 
nucleus. So, the question then becomes, what does this distinct copper-induced receptor 
internalisation pathway consist of and what are the functional implications for the cell? It has been 
previously identified that in response to its cognate tachykinin, NK3R transiently interacts with -
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arrestin 2 at the plasma membrane and activates the MAP Kinase signalling pathway upon 
desensitisation and internalisation.100 Concurrently, copper is known to directly regulate kinase 
activity via structural modification or via the inhibition of phosphatases.150 Additionally and 
specifically for the Cu2+ oxidative state, Cu2+ is proposed to disrupt the protein degradation pathway.43 
This is because of Cu2+-induced aggregation of ubiquitin, reducing its availability to the protein 
degradation pathway. This pathway requires ubiquitin to be transferred from E1-activating enzyme 
to E2-conjugating enzyme, and then finally to cytosolic proteins via E3-ligase, resulting in cytosolic 
protein ubiquitination and subsequent degradation in the proteasome.43 Therefore, this may explain 
the significant increase in overall and specifically cytosolic NK3R density in response to copper-
ligand induced activation, however, this relies on the premise that Cu2+ is endocytosed in the oxidised 
form and is not  reduced prior to entry into the cytosol.  
 
4.2.2 Nuclear copper uptake increases in response to Copper-bound Neurokinin B.  
Prior to any treatment, we first determined endogenous nuclear and cytosolic copper concentrations 
in both media incubated and copper depleted cells. We then compared the difference in 
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concentrations between the two negative control subjects to the declared manufacturers copper 
content within DMEM based complete media (Fig. 10).  
This comparison revealed that there was no significant difference between the declared 
concentration (50 to 100 ng/mL) and the concentration we detected in our complete media, but a 
marked decrease in copper in our chelex treated copper-free buffer, thus validating our 
preparations. Comparative analysis of the copper content between the different localisations (Fig. 
10) revealed that under both homeostatic and copper depleted conditions, the majority of copper is 
retained in the nucleus, with minimal fluctuation to the significantly lower cytosolic concentrations. 
The lower concentration in the cytosolic fractions may indicate the chelation or loss of copper at 
some step of the fractionation process, or the cells pumping copper back out to the extracellular 
space. However, it was persistent throughout all treatments and fractionation protocols.  
 Previously, it has been shown via synchrotron X-ray fluorescence (SXRF) imaging that in  mouse 
fibroblasts, approximately 23% of  total cellular Copper was localised in the nuclear region under 
wildtype conditions.151 Furthermore, in hepatocytes, it was shown that the nucleus played a 
significant role in initially dealing with copper overload by forming copper deposits as a protective 
mechanism, although their ability to accumulate copper over time was limited.152 This demonstrates 
that there is a significant void in CNS tissue-specific and subcellular-specific knowledge of copper 
accumulation. In contrast with the studies mentioned, our results illustrate the CNS-specific nature 
of copper regulation and dysregulation, and the unique ability and processes that astrocytes possess 
Figure 10- Identification of endogenous copper concentrations under homeostatic and 
copper-depleted conditions. 64Cu was measured for each sample and normalised to 1mg/ml of 
protein. Copper results expressed in micromoles/mg protein (y-axis). Note that the majority of 
copper is stored in the nucleus, with minimal fluctuation in the cytosol, indicative of a positive 
feedback mechanism maintaining its optimal copper levels, with any excess trafficked to the 
nucleus for storage.   
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to accumulate copper. Furthermore, it demonstrates that astrocytes employ a unique mechanism to 
accumulate copper, by forming copper pools within the nucleus, and that upon copper starvation, 
nuclear copper pools are tapped into to top up cytosolic concentrations in an attempt to maintain 
homeostasis.   
In order to ascertain whether the increased nuclear trafficking of NK3R in response to copper 
correlated with any nuclear copper accumulation, we first had to determine the approximate time it 
would take for the receptor to traffic to the nucleus. In addition, we also needed to determine what 
time would result in maximal copper uptake. In general, there is little experimental data available, 
with the majority of literature consisting of commentary reviews that speculate with minimal 
reference to any solid experimental work that explores the time dependent nature of nuclear 
receptor or metal trafficking. In one study looking at nuclear trafficking of the EGF receptor, they 
identified that within 30-90 min, there was rapid nuclear uptake of the EGF receptor, detected via 
western blotting at a molecular weight of 175 kDa.153 However, when incubated up to 3 hrs, the 
study found greater concentrations of alternative immunoreactive species, with proteins of 150 and 
130 kDa detected. These results permitted the authors to conclude that following CME of the EGF 
receptor, nuclear accumulation of the receptor occurs optimally between 30 min-3hrs. The 
timeframe makes sense given the retrograde trafficking via the Golgi-and through the sec61 
translocon.153 In another study that was looking at the nuclear uptake of the 64Cu isotope in tumour 
cells specifically, cells were incubated in 50 Ci of copper acetate for 2, 6, and 24 h. In this study, it 
was identified that after 2hrs, copper uptake was fourfold, at 6 hours, uptake remained at fourfold, 
and at 24hrs, uptake decreased twofold.154 Taking into consideration the above two studies that 
were the most relevant, and our preliminary results, it was determined that incubation time should 
be set at 2hrs to permit maximal nuclear uptake of copper and protein.   
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Nuclear and cytosolic fractions were tested for their total 63Cu content via ICP-MS, following pre-
treatment with the various constituents. Each mean was then normalised to 1mg/ml of protein. The 
Figure 11- Changes in subcellular copper concentrations in response to treatments. 
Percentage change in copper concentration from blank subcellular data in both homeostatic and 
copper-deprived conditions representative of the mean ±S.E (n=3) with (A) illustrating CuCl2 
induced changes in nuclear copper concentration (B) CuCl2  induced changes to cytosolic 
fractions, (C) NKB and [Cu
2+
(NKB)2] induced changes to nuclear fractions, and (D) NKB and 
[Cu
2+
(NKB)2] induced changes to cytosolic fractions. For each of the triplicate experiments, the 
correlation coefficient was greater than 0.9965 
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mean coefficient of variation (otherwise known as RSD, relative standard deviation) from the 
intensities of six calibration curves was 1.4%. 
 Our results in Fig. 11 A and B illustrate that in a metabolically balanced environment environment 
(i.e. cells cultured in complete media), the addition of low level free copper results in the cell 
moving copper out of the nucleus and little net change in the cytosol. As greater concentrations of 
free copper are administered, there is an active effort in a dose dependent nature to pump copper out 
of the cytosol and nuclear copper uptake is dramatically increased. This is in agreement with 
current known mechanisms of dealing with excess copper, with excess pumped out of the cell, with 
some uptake to the nucleus via an unknown mechanism.155,156 However, in contrast, in a copper-
starved environment, the addition of low dosage free copper results in  a prioritization for the free 
copper in the cytosol, presumably to restore normal copper-mediated proteins and processes such as 
in the production of ATP via mitochondrial based electron transport chain reactions. Additionally, 
when greater dosages of free copper are administered, it results in an initial shift to store copper in 
the nucleus as a coping mechanism, then a significant shift of free copper back to the cytosol in an 
attempt to export copper out into the extracellular space, or as a protective mechanism to minimise 
DNA damage caused by unbound copper. These results present a classical model of the struggle 
that the copper-starved environment places upon the cell population, trying to maintain function and 
shift copper around the cell in an attempt to restore homeostatic levels. This agrees with various 
literature exploring the effects of free copper on cellular viability.157, 158, 159   
The addition of NKB (thus utilizing a NK3R-mediated pathway) resulted in greater nuclear 
sequestering of copper from the cytosol under homeostatic conditions but exhibited the opposing 
effect under copper-starved conditions. As NKB is not found in the nucleus, it was hypothesised 
that the internalisation of NKB via NK3R endocytosis may facilitate greater availability of NKB in 
the cytosol to bind to endogenous free copper and deviate to a nuclear uptake pathway. To further 
this hypothesis, the addition of [Cu2+(NKB)2] resulted in significantly greater nuclear and to a lesser 
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extent, cytosolic uptake of copper, with higher concentrations showing a small redistribution back 
to the cytosol, presumably because the nucleus may have surpassed its copper-storing capacity (Fig. 
11 B and C). When cells were copper-deprived, interestingly the addition of [Cu2+(NKB)2] resulted 
in significant cytosolic sequestration of copper. Although the nuclear copper concentrations were 
less than untreated cells, the addition of [Cu2+(NKB)2] facilitated a dose dependent recovery of 
nuclear copper concentrations in comparison to NKB only levels in the copper-starved 
environment. This parallels the model of subcellular capacity and movement of copper exhibited by 
CuCl2 treated cells, where priority for the trafficking of copper to maintain normal cellular 
functioning is in the cytosol, but the cytosol has a minimal capacity for the storage of copper and 
therefore possesses machinery and mechanisms for utilising the nucleus for excess copper storage. 
However, where these models deviate is the pathway employed and the magnitude of the effect.  
 
Table 2- Summary of key characteristics of copper regulatory pathways that may result in 
nuclear copper uptake  
Outline of key players in copper metabolism that could contribute to the nuclear trafficking of 
the metal under homeostatic conditions, with the incorporation of our results.  
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 What these differences constitute is an interesting question indeed. In Table 2, a summary of such 
differences including our results for NK3R. The cytosolic pathway and interactions that occur once 
the [Cu2+(NKB)2]/NK3R dyad is internalised that results in greater nuclear copper concentrations is 
unknown. We do know that NKB is only found in the cytosol, so at some point in the journey it 
disassociates from the receptor. Whether Cu2+ remains bound to the receptor, disassociates, or is 
reduced is unknown. However, as previously discussed, NK3R does structurally contain a native di-
histidine site that would be capable of binding Cu2+, facilitating its trafficking to the nucleus. This 
sort of “structural transfer” is not unheard of, as the reduction of copper is currently proposed to be 
conducted by a structural element of CTR1 rather than by external reductases.  
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Chapter Five: Mobilisation of copper is mediated via 
numerous endocytic pathways
 
 
5.1 Introduction 
The complex system that permits the effective uptake, storage, and processing of metals is 
indicative of the incredibly intricate and interwoven mechanisms in which cells of the CNS deal 
with the presence of copper. Receptor mediated endocytosis (RME) is a process fundamental to 
cellular growth, nutrition and differentiation in mammalian cells. Clathrin, caveolin and most 
recently lipid rafts, mediate this method of uptake, which concludes with the successful trafficking 
of constituents to regions of the cell where they are required. As previously stated, RME is a known 
mechanism for the uptake of iron via transferrin and the transferrin receptor. Whether other 
biometals can be taken up by a similar pathway is yet to be explored.  
We have now described the endocytosis and nuclear trafficking of NK3R, as well as the 
enhancement of nuclear receptor and copper uptake induced by a copper-bound peptide ligand. 
However, in order to understand the pathway that copper takes to reach the nucleus via the 
[Cu2+(NKB)2]/NK3R internalised complex, it is necessary to establish the initial mediator in this 
process. This will establish the first biochemical steps required for internalisation and permit future 
characterisation of this novel copper uptake pathway.  
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5.2 Results and Discussion 
5.2.1 Variation of NK3R expression in astrocytes when clathrin is inhibited  
The effect of clathrin inhibition on NK3R uptake and cellular distribution was assessed following 
the addition of N-[5-[(4-Bromophenyl)methylene]-4,5-dihydro-4-oxo-2-thiazolyl]-1-
naphthalenesulfonamide (Pitstop 2), a potent clathrin inhibitor.  Structurally, Pitstop 2 works to 
inhibit the clathrin heavy chain through specific binding to the β-propeller N-terminal domain 
(NTD).161  
Figure 12- Cellular distribution of NK3R when clathrin is inhibited.  Administration of 25M   
Pitstop 2 resulted in significant inhibition of endocytosis of the receptor for most cellular 
treatments except for [Cu
2+
(NKB)2]. These results illustrate changes in nuclear and cytosolic 
NK3R localisation under FBS-free media homeostatic conditions.   
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As a result of clathrin inhibition treatment, Fig. 12 shows there is significant inhibition of NK3R 
uptake in most cell treatments, indicating that the clathrin coat assembly had been disrupted and 
that clathrin plays an important role in mediating NK3R endocytosis. There is also more NK3R 
restricted to the membrane, with ligand only treated cells resembling the control population. In the 
untreated (Fig. 12 Blank), free copper treated (Fig. 12 Cu2+ treated cells) and ligand only treated 
clathrin inhibited populations (Fig. 12 APO-NKB), there is a significant reduction in overall 
fluorescence emission, density, and uptake of NK3R. Notably, observations throughout the 
experiment indicate that the process of clathrin inhibition is very stressful for astrocytes, causing 
significant changes in morphology. These changes include the swelling of the cell, reduction in 
projections, and an enlarged nucleus. These morphological changes are indicative of possible 
changes in osmolarity, disruption to Ca2+ signalling and ion gradients, such as potassium and 
chloride channels.162,163   
Confirmation of clathrin’s role in mediating ligand induced NK3R endocytosis is illustrated through 
the dense localisation of NK3R around the periphery, although there is still some minor expression 
of NK3R within the cell and particularly the nucleus. This perhaps is due to the fact that 
endocytosis is a constant process, with clathrin coated pits constantly forming and disassembling, 
with clathrin inhibition treatment disabling the formation of these pits in an acute manner. This 
acute cessation of pit formation means that those receptors that were already in the later stages of 
the pathway or already endocytosed would remain available for activation and trafficking.124 
However, as our results illustrate, most receptors were indeed inhibited from undergoing 
endocytosis. Additionally, the administration of free copper results in even less fluorescence, 
indicating that either free copper had no effect on the activity of inhibited NK3Rs, or perhaps free 
copper in the form of Cu2+ may be quenching the fluorescence indeed.  
However, in direct contrast, the delivery of copper via [Cu
2+
(NKB)2] had the opposite effect, with 
NK3R activation, endocytosis, and nuclear localisation proceeding as if there was no inhibition. 
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This shows that clathrin inhibition had no apparent effect on inhibiting the copper-ligand mediated 
uptake of NK3R. This stark contrast strongly indicates that when clathrin is inhibited, activation 
and endocytosis of the [Cu
2+
(NKB)2]/NK3R complex still occurs unimpeded and must be utilizing 
an alternate uptake pathway. Further investigation would be required to ascertain what mediates this 
unique clathrin independent pathway.  
The ability of a receptor to utilise multiple pathways of endocytosis is not unheard of. In a recent 
study looking at the endocytosis of the EGF receptor, it was suspected that when the cell was 
exposed to an element that induces oxidative stress, the EGF receptor was unable to be internalised 
via clathrin coated pits due to receptor hyperphosphorylation.164 Interestingly, the study further 
identified that the EGF receptor instead utilised a clathrin independent pathway for endocytosis 
(caveolin mediated), with the receptor sorted to a perinuclear compartment devoid of 
ubiquitination.164 This permitted the receptors to avoid degradation, thus increasing perinuclear 
concentrations.  
We also suspect that caveolin may mediate the clathrin-independent pathway. Caveolin contains a 
scaffolding domain (DGIWKASFTTFTVTKYWFYR) that is known to bind to a receptor via a 
caveolin binding sequence motif, that is ΩxΩxxxxΩxxΩ, where the Ω is represented by either a 
Tyr, Phe, or Trp residue, as identified by Couet et al., 1997.165 Furthermore, analysis of the human 
NK3R protein using the BLAST online database, identified a sequence that is homologous to a 
caveolin binding sequence motif at residues 330-343 (WKYIQQVYLASFW)166 Thus, we propose 
that the NK3 receptor is capable of utilising multiple endocytic pathways, with its cognate ligand 
NKB utilising a clathrin-dependent endocytosis pathway and the presence of [Cu
2+
(NKB)2], 
promotes induction of a clathrin-independent method of endocytosis. Furthermore, we suspect that 
this clathrin-independence may be mediated by caveolin, which represents a clear target for future 
work.   
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5.2.2 Deviations in nuclear copper uptake upon clathrin inhibition  
Next, we examined what effect clathrin dependent and independent NK3R trafficking had on 
intracellular copper concentrations when clathrin was inhibited.  
 
In correlation with our previous NK3R localisation results (Fig.13), the nuclear copper 
concentration in blank and ligand only treated cells were significantly affected by clathrin inhibition 
(Fig. 13 A). However, in the presence of the clathrin inhibitor, [Cu
2+
(NKB)2] caused a small 
Figure 13- Comparison of homeostatic and clathrin inhibited changes to subcellular copper 
concentrations.  Administration of 25M Pitstop 2 resulted in a significant reduction of copper 
uptake overall with (A) nuclear copper concentrations exhibiting a marked reduction following 
clathrin inhibition and (B) cytosolic fractions maintaining similar copper concentrations and 
fluctuations even with clathrin inhibition. In both nuclear and cytosolic fractions, [Cu
2+
(NKB)2] 
led to a significant increase of copper concentrations in both normal and clathrin inhibited 
conditions.    
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recovery in nuclear copper concentrations. The lack of nuclear copper uptake in clathrin inhibited 
cells overall is consistent with previous work which identified that Pitstop 2 induced disruption to 
the nuclear pore complex, compromising nuclear uptake.161 This means that although [Cu
2+
(NKB)2]  
induced NK3R nuclear uptake proceeds unimpeded in the presence of the clathrin inhibitor, 
disruption to the nuclear pore complex and nuclear envelope dynamics has perhaps caused the 
disassociation of some of the copper from NK3R populations as they cross the nuclear membrane.         
In Fig. 13 B, the maintenance of similar, albeit lesser copper concentrations in the cytosol, is 
reminiscent of the pattern earlier observed in the copper-free environmental samples. That is, that, 
in astrocytes, the cytosol has a set capacity of copper that is required for essential cell functioning, 
and an attempt to maintain such is paramount, with any some of the excess shuttled to the nucleus 
or, most likely, pumped out of the cell. Furthermore, with clathrin knocked out and the nuclear pore 
complex affected, nuclear uptake is substantially reduced, indicating that excess copper was 
prevented from entering and being stored in the cell. Also, with the significant reduction of NK3R 
present in the cell overall, it demonstrates that the concentration of copper in the cell may be 
influenced by NK3R availability.  
When copper-bound NKB is present, there is a minor increase in copper concentrations as well as 
altered NK3R localisation, but the significant decrease in comparison to the non-clathrin-inhibited 
indicates that the cytosolic binding of free copper to Apo-NKB that is endocytosed via activation of 
NK3R is likely clathrin mediated. However, as NK3R nuclear localisation results for uptake via the 
[Cu
2+
(NKB)2]/NK3R complex was relatively unaffected by clathrin inhibition (Fig.12), with the 
complex causing greater copper concentrations both in the nucleus and the cytosol in comparison to 
the blank (Fig. 13 A and B), it indicates that [Cu
2+
(NKB)2] may be circumventing the clathrin 
mediated pathway.  
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The discrepancy between the continuation of NK3R nuclear uptake and the significant drop in 
nuclear copper uptake, albeit greater than the blank, is difficult to reconcile because it is believed 
that copper traffics as a complex with NK3R. Therefore, we hypothesise that if indeed 
[Cu
2+
(NKB)2] utilises a clathrin independent pathway when clathrin is unavailable, that changes in 
the immediate endocytic microenvironment may result in the earlier disassociation of Cu2+ at some 
point of the process, preventing the nuclear localisation of copper. This may possibly be a result of 
changes in pH in the clathrin -inhibited vesicular microenvironment, as one study identified the 
recruitment of caveolin to late endosomal/lysosomal vesicles was pH and cholesterol dependent.167 
This is interesting as previously stated, we suspect caveolin may be involved in the clathrin-
independent pathway for NK3R. Furthermore, Cu2+ can disassociate from complexes in a more 
acidic environment, as it has been previously demonstrated for Cu2+ bound  amyloid, thus, this 
hypothesis may explain our results observed.168   
This further shows that the majority of copper that enters the cell and subsequently the nucleus is 
likely mediated by clathrin, with a small proportion entering via other pathways. These pathways 
may include the currently well-known DMT1 and CTR1 mediated routes, however recent research 
indicates that even these processes may be mediated by clathrin.169 Our results illustrate a direct 
relationship between nuclear copper uptake and NK3R localisation that likely utilises a clathrin-
independent pathway to maintain nuclear NK3R populations and attempt to deliver copper to the 
nucleus.   
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Chapter Six: Spectral Phasor Analysis reveals copper-NKB 
induced changes in NK3R nuclear micro-environments. 
 
 
6.1 Introduction 
Fluorescence lifetime imaging microscopy (FLIM), is a method that permits further analysis of 
protein localisation with high spatial and temporal resolution, independent of excitation intensity or 
fluorophore concentration.170 Spectral phasor analysis similar to FLIM, in that it fourier transforms 
the phase and the amplitude to generate G and S co-ordinates. deconvoluting the fluorescent signal 
into wavelength and width, with shifts in co-ordinate distribution of pixels indicative of micro 
environmental changes.  
In order to further explore the confocal microscopy results, specifically the nuclear redistribution of 
NK3R induced by copper-bound NKB, we utilised a quantitative approach using Spectral Phasor 
Analysis. This will allow us to acknowledge whether possible changes to pH, protein and molecular 
interactions, or ion concentration and DNA conformations, have led to the alteration of nuclear 
microenvironments upon the uptake of copper and NK3R.  
6.2 Results and Discussion 
6.2.1 Copper-bound Neurokinin B induces significant shifts in spectra within the nucleus of 
astrocytes 
Ascan was first obtained for individual cells of our control and 3 M [Cu2+(NKB)2] treated 
populations. This was repeated three times, with all cells analysed exhibiting parallel spectral 
profiles, thus the individual cell results illustrated are representative and treated as the mean of 
those experiments. As a consequence of applying a threshold mask in the photon counting 
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histogram, the emission of spectra from the extracellular space and the cytoplasm was eliminated 
from analysis.           
 
In Fig.14, Spectral imaging of both the control and treated cells reveals two distinct subpopulations 
of NK3R emitting different emission profiles, one subpopulation residing at the nuclear envelope, 
and the other inside the nucleoplasm. These subpopulations may be a result of transient states or 
protein interactions, as other nuclear proteins are known to exist in various states.171 Upon copper-
ligand induced endocytosis of NK3R into the nucleus, there is significant movement of NK3R into 
Figure 14- Variations in nuclear spectral emission induced by [Cu
2+
(NKB)
2
]. Visual 
representation of the spectral emission in the form of a scatter plot (the phasor plot). The shape, 
size and co-ordinates of the phasor with background emissions once removed, revealed a copper-
ligand induced shift in both amplitude and phase, as well as an increase in the size of the phasor 
emitted by CF-568 conjugated to NK3R.  
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the nucleus, with two copper-induced NK3R populations with differing  max present in many 
parts of the nucleus, except for the nucleoli. In both images, NK3R is present in cajal bodies and the 
nucleoplasm, but absent from nucleoli. This is interesting as knowledge around NK3R’s function in 
the nucleus is in its infancy. Its presence in these areas of the nucleus suggest a possible role in 
histone modification, trasncriptional regulation as well as mediating copper accumulation. 
Moreover, a lack of fluorescence in the nucleolus indicates that NK3R does not play a role in the 
synthesis of ribosomal RNA or ribsomal assembly.     
Figure 15- Quantification and spectral distribution of the nuclear spectral shift induced by 
[Cu
2+
(NKB)
2
]. Regional nuclear distribution of emission characteristics λmax and spectral 
width reveals significant spectral shifts in the nucleus once NK3R is activated by [Cu
2+
(NKB)2] 
and translocates to the nucleus. There is a significant narrowing of spectral width and an 
increase in density in a reduced  max distribution across spectra. Control cells had a mean 
max of 491.9 and a mean width of 137.2, with a SD of 15.2 and 77.8, and a SEM of 2.5 and 
12.8 respectively. In contrast, copper-bound NKB cells had a mean max of 472.3 and a mean 
width of 29.1, with a SD of 6.2 and 5.6, and a SEM of 0.7 and 0.6 respectively.  
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It has previously been noted that the breadth of an emission is indicative of the degree of 
heterogeneity in cellular processes. An emission with a broad width consists of multiple 
wavelengths and varied intensities.172 The individual wavelengths are indicative of specific 
molecular environments or biochemical processes. 
As shown in Fig. 15, the breadth of emission data (wavelength and peak width)  for control cells is 
wide, reflective of the cellular heterogeneity in processes occurring at that point in time within the 
nuclear environment. However, in [Cu2+(NKB)2] treated cells, there is a significant reduction in 
cellular process heterogeneity. This indicates that when  [Cu2+(NKB)2] induces endocytosis of 
NK3R and the subsequent increase in receptor nuclear localisation and copper uptake, there is a 
concerted effort by the cell to dedicate resources to mount a specific biochemical response, 
exhibited by the reduction in width and wavelength variation. This effect has been reported in a 
previous investigation of Na+ microenvironmental fluctuations during the early stages of myoblast 
differentiation.170 Because there is such a significant spectral shift induced by [Cu2+(NKB)2], excess 
nuclear copper and additional NK3R present, our spectral results indicate that there is a significant 
change in any or some of the nuclear environmental conditions of NK3R. Whether it is indeed a 
change in pH, protein-protein interactions such as oligomerization, or the binding of  copper 
directly to the receptor remains to be elucidated.  
These results collectively illusttrate that copper-bound NKB induced biochemical or 
microenvironmental changes in the nucleus. Furthermore, our results implicate NK3R in having a 
role in nuclear copper accumulation and possibly different functions dependent upon the nuclear 
biochemical microenvironmental conditions. However, we also suggest that this change may also be 
a change in protein dynamics, that is, that the spectral shift is a result of copper transferring to 
NK3R from NKB as it enters the nucleus, leaving NKB behind in the cytosol. In order to further 
explore this, greater analysis is required, which was beyond the scope of this work. The 
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incorporation of a second copper-sensing flurophore and FRET analysis is expected to further 
elucidate these interactions.  
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Chapter Seven: NK3R expression in neurons differs to 
astrocytes: novel roles within the tripartite synapse. 
 
 
7.1 Introduction 
The sophisticated nuclear uptake of NK3R and associated interactions with copper, provides clues 
into copper metabolism more broadly that may be applicable beyond the frontiers of the astrocyte. 
As a functional member of the tripartite synapse, the uptake and storage of excess copper from the 
synapse to the astrocyte is fundamental to the maintenance of functional synapses and neurons more 
broadly. As astrocytes and copper more specifically, are key regulators in the formation and the 
arrangement of synapses during neurogenesis173, it is reasonable to query the presence and 
distribution of NK3R during proliferative and differentiate phases of neuronal development.         
Considering what we have demonstrated thus far and learnt about NK3R and its probable role in 
copper regulation, we decided to see if some of these principles we saw in astrocytes also apply to 
neurons. Considering there is now a greater understanding on the concept of the tripartite synapse 
and how incredibly important astrocyte-based regulation of copper is to neuronal function173, it is 
imperative that we identify neuronal based NK3R expression and any similarities and differences in 
NK3R dynamics.   
7.2 Results and Discussion 
7.2.1 NK3R expression in undifferentiated vs differentiated neurons 
A qualitative approach to identifying NK3Rs in neurons was employed to determine the spatial 
distribution and architectural properties of the receptor in both undifferentiated and differentiated 
cell populations.  
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In Figure 16 (undifferentiated), immunofluorescent analysis of NK3R shows a predominant nuclear 
localisation with dense punctuate pattern, similar to vesicular like structures. The is also notably 
less fluorescence in what appears to be nucleoli, suggesting that NK3R is excluded. In Figure 16 
(differentiated), the distribution of NK3R has shifted, with greater peripheral localisation, with 
Figure 16- Endogenous localisation of NK3R in SH-SY5Y neurons. Nuclear localisation in 
control undifferentiated neurons is significantly greater to that of control astrocytes, displaying a 
distinct punctuate pattern but like astrocytes, NK3R is notably absent from nucleoli. In 
differentiated neurons, nuclear receptor uptake is lesser and resembles more like astrocytic 
distribution. Notably, the presence of distinct punctuate patterns of dense NK3R in the nucleus, 
along axons and dendrites resemble vesicular storage of NK3R, with the presence of both pre 
and post synaptic neurons.  
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dense vesicles containing NK3R present in dendrites. Although the nuclear localisation remains 
punctuate, the density has reduced, although still substantial.  
Accordingly, three broad themes emerged from the dataset, that is, that NK3R is significantly 
expressed in the nucleus of neurons, during neurogenesis it is exclusively in the nucleus at 
substantial levels, and it is exclusively stored in vesicle like structures both in the nucleus and upon 
differentiation, along the periphery pre and post synaptically.           
Proteomic expression and distribution within undifferentiated neurons and indeed all neural 
progenitor cells are not very well chraterised overall. The dynamics behind neurogenesis are only 
starting to be understood, with various GPCRs and metals identified as playing a vital role in 
proliferation and differentiation.  
The neuronal experiments revealed striking evidence of nuclear NK3R expression, density and 
localisation in neurons, both during proliferation and differentiation. Interestingly in both 
populations, the nucleus has significant endogenous NK3R stored in vesicles.  There is also a 
significant redistribution upon differentiation, with the migration of some vesicles to axons and 
dendrites, indicating a role for endocytosis and vesicular trafficking of NK3R at synapses. 
Furthermore, the prominence of endogenous NK3R nuclear expression is in stark contrast to 
endogenous astrocyte expression, implicates an unknown role for NK3R in the nucleus that is 
neuron-specific.   
One other study identified in undifferentiated SH-SY5Y cells a similar pattern of densly packed 
nuclear vesicles.174 Interestingly, they also identified upon purification that these vesicles contained 
significant concentrations of  dopamine hydroxylase, chromogranin A, noradrenaline and 
neuropeptide Y.174 Furthermore, in another study, it established that tau protein was significantly 
stored in vesicles within the nucleus as well.175 These studies along with Fig. 16 results, confirm 
that during neurogenesis, many neuropeptides, receptors, and neurotransmitters are produced en 
masse in the nucleus and are stored in vesicles, including NK3R. Each of the constituents expressed 
103  
  
have roles during neurogenesis, therefore the novel finding of excessive NK3R in vesicles of the 
nucleus infer that NK3R may have a distinct role during neurogenesis.  
It is well known that copper is essential for neonatal development and the differentiation of 
neurons.173 Menkes disease is an excellent example of the detrimental effects of  poor copper 
distribution, with the chronic starvation of copper to the CNS eventually causing death if left 
untreated.176 Our differentiated neurons were presumed to posess a cholinergic neuronal phenotype, 
due to the use of trans-retinoic acid to induce differentiation. They are known to also express may 
dopaminergic receptors that interact with copper pathways, such as tyrosine hydroxylase, 
dopamine-beta-hydroxylase, and dopamine transporter.177 Furthermore, upon differentiation 
proliferation ceases and neuronal spiking commences.  It is well known that upon differentiation, 
neuronal spike frequencies increase substantially, initially random and then becoming more 
synchronised over time.178 With depolarisation, comes a redistribution of labile copper pools from 
the soma to the periphery.179 This parallels the results we observed in the redistribution of NK3R to 
the periphery upon differentiation (Fig.16), suggesting that the correlative relationship between 
NK3R and copper in astrocytes may be replicated in neurons, although the functional outcomes and 
interactions may differ. As a consequence of these results, further investigating and characterisation 
of NK3R mediated copper uptake in neurons is warranted.     
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Chapter Eight: Conclusion
 
 
One of the significant challenges scientists currently face is unravelling the molecular basis for 
neurological disease. Over the years, many have identified copper dysregulation as playing an 
integral role in the aetiology of several neurodegenerative disorders.1,9, However, with little 
pharmacological progress made, many have either overlooked, or dismissed copper altogether, 
questioning its importance in pathology.  
Currently, there is a good understanding of the main copper uptake pathways that primarily utilise 
CTR1 and DMT1, with other copper transporters and copper-binding proteins identified. 
Furthermore, the reactivity of copper, both in redox reactions and in its ability to induce 
biochemical responses are very well known. However, it has repeatedly been demonstrated that 
beyond the two main uptake pathways, there remains other subtler copper uptake pathways in the 
CNS yet to be identified.32 In Christofides et al, 2018,101 it was hypothesised that G protein-coupled 
receptors may play a greater role in metal trafficking than previously thought. Many GPCRs 
possess the capacity for highly specific ligand binding and trafficking using endosomal structures. 
For metals, these functional properties of GPCRs presents a process by which metal-based cargo 
trafficking may occur.  
In this study we set out to determine the localisation and distribution of NK3R in response to free 
copper, its cognate ligand NKB, and the newly discovered complex [Cu2+(NKB)2], and what effect 
treatment with [Cu2+(NKB)2] had on cellular copper accumulation. Additionally, we further 
highlighted trafficking and accumulation in the nucleus of neuronal cells.  
The investigation of endogenous NK3R by immunoblotting showed that NK3R within astrocytes 
exists both in the cytosol and the nucleus as a monomer and in a high molecular weight, presumably 
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hetero/homomeric, state. The presence of high molecular weight GPCR multimers after 
electrophoresis under reducing/denaturing conditions indicates the protein is highly resistant to 
denaturation. In addition to the formation of multimers it is possible that high molecular weight 
NK3R is due to binding other proteins such as chaperones, heat shock proteins, or even histones in 
the nucleus. When the distribution of NK3R in the cell was investigated by immunofluorescence 
the result confirmed the immunoblotting. NK3R was identified in the cytosol and had robust 
expression in the nucleus. Differentiated neurons exhibit similar localisation of NK3R to that of 
astrocytes, with the only difference being greater vesicles full of NK3R located pre and post 
synaptically, and along the periphery. However, in undifferentiated neurons, there is intense density 
and localisation of NK3R in the nucleus, indicating a significant role for the protein during 
neurogenesis.  
The second major finding of this study is when the [Cu2+(NKB)2], induced endocytosis of NK3R 
was investigated. This revealed that the complex is unique and evokes a substantial response within 
astrocytes in a dose-response manner.  Upon exposure, NK3R is activated, is endocytosed, and 
trafficked to the nucleus. This coincides with a significant uptake of copper to the nucleus. It 
appears that the NK3R bound copper-ligand complex undergoes endocytosis and traffics to the 
nucleus (Chapter 3). Intriguingly, NKB is not found in the nucleus, but both the copper and the 
receptor are. This suggests that during endocytosis copper is transferred from [Cu2+(NKB)2] to 
NK3R. The punctuate nature of nuclear NK3R suggests that either oligomerisation or associations 
with other nuclear proteins occurs. Furthermore, the localisation within cajal bodies and the nuclear 
matrix, but absence from nucleoli suggests a functional role for NK3R in transcriptional regulation, 
acting as a transcriptional co-factor and/or histone modification.  
There are minimal fluctuations in cytosolic copper, with our results illustrating the majority of 
copper is retained in the nucleus of astrocytes, demonstrating that astrocytes possess numerous 
feedback mechanisms to maintain necessary copper in the cytosol for functioning, and an astrocytes 
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ability to deal with an influx of copper in the extracellular space includes endocytosis and nuclear 
translocation. When copper uptake is beyond the capacity of the nucleus, there is an active effort to 
pump copper back out into the cytosol to be pumped out of the cell (Chapter four) in an attempt to 
save the cell from an apoptotic pathway. Furthermore, cells change morphologically, and infer that 
they are under osmotic shock. Likewise, upon copper starvation, nuclear copper uptake is diverted 
to the cytosol to maintain homeostasis. This is in agreement with the current understanding of the 
astrocytic regulation of copper during diseased states180 and demonstrates a CNS specific 
mechanism for copper accumulation and distribution that is mediated by NK3R.    
Thirdly, one of the more significant findings to come from this study is in relation to the 
mobilisation of copper by numerous pathways. We demonstrated that endogenous, free copper, and 
apo-NKB induced NK3R trafficking is clathrin mediated, but notably [Cu2+(NKB)2], induced 
NK3R endocytosis appeared to circumvent the clathrin-inhibited pathway (Chapter five). 
Presumably, [Cu2+(NKB)2] can promote endocytosis by a non-clathrin mediated pathway. Non-
clathrin mediated pathways are well known and include caveolin dependent and independent 
pathways, yet the specific pathway utilised by [Cu2+(NKB)2] activated NK3R remains to be 
elucidated. Further to this, the complex invoked a significant shift in the nuclear microenvironment, 
as detected by spectral phasor analysis (Chapter six). In agreement with our previous results, there 
were two substantial nuclear subpopulations of NK3R, with [Cu2+(NKB)2] mediated uptake of 
NK3R causing an increase in both nuclear subpopulations and overall influx of the receptor. This 
influx was shown to change the nuclear environment. We believe that this change may be due to a 
change in pH, protein-protein interactions (multimerization) and the presence of copper.  
All these findings in general suggest that the action of [Cu2+(NKB)2] and NK3R can lead to nuclear 
uptake and retention of copper. Both NK3R and copper have the capacity to influence many 
functions in the nucleus, contributing through an endocytosis pathway to the overall action of many 
other established pathways in CNS-specific copper regulation. Furthermore, it signifies that copper 
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regulation in the brain may be far more complex than previously assumed, and the induction of 
various pathways may occur, with each pathway possibly responsible for eliciting a different 
cellular response. The usefulness of the complex to significantly increase nuclear copper 
concentrations via a RME pathway, may represent a distinct manner by which metals can enter the 
nucleus successfully, and indicate that induction of such a mechanism may present a unique 
functionality within the nucleus. 
8.1 Significance 
The present study makes several noteworthy contributions to understanding copper regulation in the 
brain. Furthermore, the current findings add to a growing body of literature on the contribution 
copper dysregulation has in many neurodegenerative and neurocognitive diseases.  
Previous research has failed to address many gaps in primary scientific knowledge on copper 
accumulation and protein interactions. For example, we know most of the key proteins that interact 
with copper and its function in the nucleus, but little about how copper reaches the nucleus. 
Furthermore, many clinical trials of NK3R antagonists, implicated in treating a wide variety of 
neurological illnesses, have experienced small effect sizes, conflicting trial results and failure to 
progress to later stages due to the rationalisation of clinical trials in general 181, 182 We speculate that 
in many cases of clinical trials not progressing, this is more likely due to factors such as 
inappropriate experimental models for pre-clinicals, inappropriate patient selection and recruitment, 
lack of genetic validation, and perhaps the most telling, a lack of fundamental understanding of the 
structural basis of an antagonist’s interaction with NK3R and the subsequent cell biology of the 
receptor.  
Following these failures, another study identified that only cell surface, not nuclear translocated 
NK3 receptors were blocked by an NK-3 antagonist.110 Thus, providing a likely explanation as to 
why so many clinical trials have inconclusive or mixed results. Also, it would be in agreement with 
our results which demonstrated that when activated by its cognate copper-bound ligand, there is a 
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significant subpopulation of receptors that translocate to the nucleus and corresponds with an influx 
of copper to the nucleus. Furthermore, we demonstrated that if copper was trafficking to the nucleus 
via the complex in vivo, any pharmacological agent that impairs clathrin mediated endocytosis 
would be ineffective in significantly effecting NK3R nuclear translocation.  
As far as the significance of the delivery of NK3R and copper to the nucleus, we predict that NK3R, 
like other copper binding proteins, forms part of the nuclear milieu of proteins that either have an 
indirect transcriptional regulatory role, or a more direct role, binding to other nuclear constituents. 
As such, this work has significant implications for pharmacological development for many illnesses 
where both NK3R and copper play a role and targeting nuclear concentrations is required. For 
instance, an exciting development in pharmaceutical research is the novel class of compounds 
called Metal Protein Attenuating Compounds (MPACs). These compounds are not direct chelators 
of copper, but rather they cross the blood brain barrier (BBB) and bind to metals with moderate 
affinity, attenuating the metal from interacting with a protein/peptide. These compounds have been 
trialled in the treatment of Alzheimer’s disease to disrupt the binding of Cu2+ and Zn2+ to Aβ 
peptide, preventing its oligomerization.183 This had promising results, claiming to slow dementia 
and cognition loss.  
Development of other compounds that could be applied to NK3R are mediators of metal responsive 
elements (MREs). MREs have previously been shown to bind to a metalloprotein’s promoter 
sequence, necessary for the upregulation of the protein’s transcriptional activity and 
bioavailability.184 If these responsive elements also exist for NK3R, then mediators could be used as 
a completely different approach, disrupting the binding of MREs to the promoter sequence, and 
acting as a transcriptional antagonist.  
In contrast, several limitations to this study need to be considered. Firstly, characterisation of the 
different conformational states of NK3R was beyond the scope of this study. Secondly, our 
hypotheses may only be applicable to a subset of cells due to the heterogeneity of astrocytes that is 
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spatially dependent. This is also reflective of the heterogeneous biochemical landscape within the 
nucleus, where numerous distinct subpopulations of NK3R exist that have the possibility of 
different functional properties. Thirdly, identification of the oxidative state of intracellular copper 
once it has been internalised is required. There is next to no literature that looks at whether 
intracellular copper exists in different oxidative states, when bound to NK3R or for any other 
protein, and specifically for when it resides in the nucleus. The ability of NKB to bind reduced 
copper (Cu+) might suggest that trafficking of copper will occur irrespective of oxidation state.185 
At the moment, this is attributed to technological hurdles that make it difficult to use Cu+ in cell 
culture. Only recent developments in copper-sensing fluorophores that are sensitive to copper’s 
oxidation state provide a feasible way to definitively confirm that a protein is indeed bound to a 
particular species of copper in an intact live cell.186 However, the inherent fluorescence-quenching 
properties of Cu2+ means that development of a Cu2+ -specific probe is difficult. Also, what remains 
unexplained is why administration of the copper-bound complex consistently resulted in a 
significant increase in the emission of the immunofluorescence of NK3R. This study was 
unfortunately limited in identifying any possible interactions between the NK3R bound fluorescent 
secondary antibody and Cu2+ that resulted in enhanced emission rather than the expected quenching 
of the fluorescence. Furthermore, we believe that this effect is not isolated as preliminary testing 
with an alternate Alexa 488 Secondary antibody yielded the same result. When compared to the 
administration of free copper, we do not see additional emission, showing that free copper has 
perhaps quenched fluorescence, but with our ligand-bound copper there is this unique effect that is 
unaccounted for. Overall, these limitations mean that study findings need to be interpreted 
tentatively, until further characterisation and exploration is undertaken.   
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8.2 Recommendations for future work 
In order to further build upon the significant body of evidence presented in this study and to further 
characterise the relationship of NK3R in copper regulatory pathways, it is important for future 
research to overcome the limitations identifed and to consider the suggestions made below.  
Further research is needed to account for the varying bands of nuclear and cytosol specific NK3R 
molecular weights detected. Western blot analysis after treatment with the enzyme PNGase  would 
reveal whether the various cytosolic bands are as a result of the protein being glycosylated. 
Furthermore, using a histone-specific antibody or other methods of detection of oligomerization 
may need to be employed. One such new method is using  Spatial intensity distribution analysis 
(SpIDA).  It further develops confocal images to quantify protein present through fluorescence 
intensity histograms through super-Poissonian distribution functions.187 This allows density and 
quantal brightness values of the fluorophore-labelled protein.  Furthermore, beyond protein 
quanitifcations, it allows the study of oligomerisation.187 This has been done previously to other 
GPCRs, such as, class a rhodopsin receptors, and also to tyrosine kinases.188,189 Normalisation of 
values obtained to the known quantal brightness of the fluorophore in its monomeric state permits 
identification and quantification of the density in particles per μm2 and the oligomeric state in 
monomeric equivalent units (MEUs) of the protein of interest.169    
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